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ENAC REGULATION IN THE KIDNEY THE ROLE OF ANKYRIN G 
Christine A. Klemens, Ph.D. 
University of Pittsburgh, 2017 
The epithelial sodium channel (ENaC) is the limiting entry point for Na+ reabsorption in the distal 
kidney nephron and is regulated by numerous hormones, including the mineralocorticoid hormone 
aldosterone. Previously we identified ankyrin G (AnkG), a cytoskeletal protein involved in 
vesicular transport, as a novel aldosterone-induced protein that can alter Na+ transport in mouse 
cortical collecting duct cells. AnkG is highly expressed in the kidney, particularly in the distal 
nephron. Increasing AnkG expression increases ENaC activity while depleting AnkG reduces 
ENaC-mediated Na+ transport. The underlying mechanism presiding over this effect; however, 
was unknown. Here we report that AnkG expression directly regulates Na+ transport by altering 
ENaC activity in the apical membrane. These changes are due to a change in ENaC directly rather 
than through alterations to the Na+ driving force created by Na+K+ATPase. Using a constitutively 
open mutant of ENaC and surface biotinylation, we demonstrate that the augmentation of 
Na+ transport is caused predominantly by increasing the number of ENaCs at the surface rather 
than alterations to open probability. To determine the mechanism of AnkG action on ENaC surface 
number, changes in rates of internalization, recycling, and membrane delivery were investigated. 
AnkG did not alter ENaC delivery to the membrane from biosynthetic pathways or removal by 
endocytosis; however, AnkG did alter ENaC insertion from constitutive recycling pathways. We 
also investigated the potential role of a putative AnkG binding domain in the C-terminus of 
βENaC, and whether single-site mutations of a charged residue and two regulatory 
phosphorylation sites could disrupt AnkG augmentation of ENaC current. We did not find any 
significant evidence that this region is essential for AnkG-ENaC interaction. These findings 
v 
provide a mechanism to account for the role of AnkG in the regulation of Na+ transport in the distal 
kidney nephron. 
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1.0  INTRODUCTION 
1.1 KIDNEY PHYSIOLOGY 
The physiological role of the kidney is to regulate the fluid and electrolyte balance of the body in 
order to preserve extracellular fluid volume, solute concentrations, and acid-base balance, as well 
as removing waste and unneeded metabolites. It does this by filtering the blood then reabsorbing 
water and solutes while excreting waste along the functional unit of the kidney, known as the 
nephron. At rest, the kidneys receive 20% of the cardiac output, and filter roughly 180 liters of 
filtrate per day, generating ~1-2 liters of urine. Each kidney contains a million nephrons on 
average, and each nephron has an associated blood vessel network. The nephron is comprised of 
different segments, which have different roles in the filtration, secretion, and reabsorption of 
various solutes. Figure 1.1 is a diagram of these different segments. As blood passes from an 
afferent arteriole into a capillary bed associated with the glomerulus, fluids are filtered from the 
blood into Bowman’s capsule and transported to the first tubular section, the proximal tubule. After 
this the filtrate passes through the thin descending and ascending loop of Henle, then moves onto 
the thick ascending limb. Lastly, the filtrate passes through the hormonally regulated distal 
nephron comprised of the distal convoluted tubule and collecting duct, where the last of the 
essential solutes and water are reabsorbed while the remaining filtrate is excreted and collected in 
the bladder. 
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Figure 1-1. The Nephron. Blood is filtered through the glomerulus into Bowman’s capsule, after 
which the filtrate progresses through the proximal tubule, thin descending limb of Henle, thin 
ascending loop of Henle, the thick ascending limb, distal convoluted tubule, and lastly the 
collecting duct before excretion into the bladder. 
1.1.1 Glomerulus and Bowman’s Capsule 
The lacy, globular structure of the glomerulus is formed by podocytes and intraglomerular 
mesangial cells. Blood from the afferent arteriole empties into a fenestrated capillary bed, and 
water and solutes are transported across the glomerular filtration barrier as a result of both 
hydrostatic and oncotic forces. This barrier is comprised of the basement membrane lying between 
the capillary endothelial cells and slit diaphragms formed by the interdigitating foot processes of 
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the podocytes. When healthy and intact, this barrier prevents movement of molecules larger than 
40 kilodaltons (kDa) into Bowman’s space, and the filtrate moves to the urinary pole and enters 
the proximal tubule. 
1.1.2 Proximal Tubule 
The main function of the proximal tubule is bulk reabsorption of glucose, amino acids, ions, water, 
and other small metabolites. The proximal tubule is responsible for reabsorption of 65-70% of 
water, 60-70% of sodium (Na+) and potassium (K+), ~80% of bicarbonate, 40-50% of calcium 
(Ca2+), 80% of phosphate, and nearly 100% reabsorption of glucose, citrate, and small peptides. 
Much of the absorption is driven by secondary passive transport coupled to Na+ moving from a 
higher extracellular concentration to a lower intracellular concentration, although solutes and 
water can also pass paracellularly. The basolateral membrane is highly in-folded with numerous 
Na+K+ATPase (NKA) transporters to maintain the low intracellular Na+ concentration driving 
secondary transport, while the apical membrane has microvilli to increase absorptive surface area 
and dedicated endocytic machinery to allow the fast internalization and recycling of receptors such 
as megalin, which has a variety of different ligands in the proximal tubule [1].  
1.1.3 Loop of Henle 
The tubule sections of the loop of Henle in combination with the vasa recta (the network of 
capillaries surrounding the loop of Henle) are essential for the formation of hypertonic urine in 
birds and mammals, and is comprised of the thin descending limb, the thin ascending limb, and 
the thick ascending limb [2]. To do this, the tubules use a countercurrent multiplier system, which 
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allows the nephron to intake more solute than water, resulting in hypertonic urine. The thin 
descending limb is transcellularly and paracellularly permissive to water transport, but has low 
permeability to ions and urea, resulting in increased luminal osmolarity as the filtrate approaches 
the hairpin turn to the thin ascending limb of Henle. Along the thin ascending limb, ions and small 
solutes can be reabsorbed, but this portion is impermeable to water. Lastly, the thick ascending 
limb (TAL) is also impermeable to water, and uses energy to actively transport Na+, K+, and Cl- 
from the lumen filtrate creating a hyperosmotic interstitial space in the renal medulla, carried by 
the vasa recta flowing in the opposite direction. This hypertonic interstitial space drives the passive 
diffusion of water from the lumen of the descending limb, while the hypertonicity of the thin 
ascending limb drives passive diffusion of ions out of the luminal space. Meanwhile, the vasa 
recta, returns the absorbed water back into the circulatory system.  
1.1.4 Macula Densa 
At the end of the thick ascending limb and before the distal convoluted tubule are a group of cells 
known as the macula densa. The macula densa are a collection of 15-20 cells that are closely 
associated with the juxtaglomerular apparatus, which itself is comprised of extraglomerular 
mesangial cells and juxtaglomerular cells in the afferent arteriole. These specialized cells function 
as salt sensors that use paracrine signaling to initiate tubuloglomerular feedback control of 
glomerular filtration rate, and hormonal fine tuning of salt excretion in the distal nephron. Salt-
sensing takes place on the apical, lumen-facing surface via Na+2Cl-K+ cotransporter (NKCC2), 
and the Na+H+ exchanger (NHE2), and directs intracellular signaling through changes in 
intracellular Cl- and Ca2+ concentrations, changes in membrane potential, and changes in pH [3, 
4]. Low tubular salt concentrations activates a phosphorylation cascade leading to release of 
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prostaglandin which in turn triggers renin release from the granular juxtaglomerular cells and 
initiates renin-angiotensin-aldosterone signaling which will be discussed in further detail below 
[3]. 
1.1.5 Distal Convoluted Tubule 
Despite being the shortest segment of the nephron, the distal convoluted tubule (DCT) plays an 
essential role in Na+, K+, Ca2+, and Mg2+ homeostasis [5]. In the DCT, Na+ reabsorption is 
increased following stimulation with the mineralocorticoid hormone, aldosterone, or increased 
luminal Na+ load, while Ca2+ uptake is regulated by parathyroid hormone. The DCT is divided into 
two segments, the DCT1 and DCT2, which are defined by their response to aldosterone. The DCT2 
is more responsive due to expression of the enzyme 11-β hydroxysteroid dehydrogenase 2, that 
reduces cortisol to inactive cortisone, freeing mineralocorticoid receptors from circulating levels 
of cortisol and enhancing the aldosterone response [5].  
DCT cells have deep basolateral infoldings which are packed with mitochondria to power 
active transport of Na+ and K+ via the NKA. Na+ reabsorption in the DCT is driven primarily by 
the Na+Cl- cotransporter (NCC) on the apical membrane down the concentration gradient 
generated by NKA, although it is worth noting that the epithelial Na+ channel (ENaC) is expressed 
in DCT2 as well [5]. NCC is the therapeutic target of thiazide-type diuretics and accounts for 
roughly 5-10% of the reabsorbed filtered Na+. Aldosterone and increased luminal Na+ load 
activates the WNK-SPAK/OSR1 signaling cascade, which results in increased active, 
phosphorylated NCC at the apical membrane. For further insight, several excellent reviews are 
available [6-9]. Apical Cl- transport is linked to Na+ transport and extruded basolaterally by the 
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chloride channel ClC-Kb and its accessory protein Barttin, as well as the K+Cl- cotransporter 
(KCC4) [5].  
Reabsorption of Ca2+ in the DCT is approximately 7-10% of the filtrate load and is 
regulated by parathyroid hormone. While Ca2+ reabsorption occurs passively and through 
paracellular pathways in other regions of the nephron, in the DCT, Ca2+ is actively transported 
transcellularly via transient receptor potential channel subfamily V member 5 (TRPV5) [10], 
bound in the cytosol by intracellular chelators, and extruded basolaterally by the Na+Ca2+ 
exchanger (NCX1) or Ca2+ATPases. Lastly, the DCT reclaims about 10% of the filtered Mg2+ via 
active transcellular transport through the transient receptor potential cation channel subfamily M 
member 6 (TRPM6) [11]. The mechanism by which Mg2+ is moved across the basolateral 
membrane has yet to be elucidated. 
As the filtrate travels down the DCT, the luminal K+ concentration increases as K+ is 
secreted through voltage-dependent and flow-rate dependent mechanisms. Expression of the 
electrogenic Na+ channel ENaC further down the DCT creates a lumen-negative stimulus for K+ 
secretion through renal outer medullary K+ channels (ROMK). Additionally, shear stress activates 
“big-conductance”-K+ channel (BK), which also contributes to K+ secretion in the DCT (as well 
as CCD). 
1.1.6 Collecting Duct 
The collecting duct (CD) is responsible for reabsorption of 2-5% of the filtered Na+ load and can 
be subdivided into the connecting tubule (CNT), the cortical collecting duct (CCD), the outer 
medullary collecting duct (OMCD), and the inner medullary collecting duct (IMCD). Within the 
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tubules, there is a heterogenous population of 2 cell types; namely, the principal cells and the 
intercalated cells. The principal cells predominantly control Na+ and water reabsorption and K+ 
secretion, while the intercalated cells play a role in maintaining acid-base homeostasis. This region 
of the nephron is highly sensitive to a number of hormones, including aldosterone, arginine 
vasopressin (AVP, also known as anti-diuretic hormone ADH), angiotensin II, atrial natriuretic 
peptide, and insulin, allowing tight regulation of water and solute concentrations before urine 
moves to the bladder [12]. 
1.1.6.1 Transport in Intercalated Cells 
The intercalated cells of the CD can be divided in to three groups: type-A, type-B, and non-A/non-
B intercalated cells, which are determined by the presence of pendrin and/or the anion-exchannger 
(AE1) and the localization of H+ATPase [13, 14]. The predominant function of type-A intercalated 
cells is to secrete H+ via H+ATPase, while type-B cells secrete anions (HCO3-, I-, Cl-) via pendrin 
and reabsorb Na+ through the Na+-driven Cl-/HCO3- exchanger (NDCBE), and non-A/non-B cells, 
which also express apical pendrin secrete anions [13]. Additionally, intercalated cells can reabsorb 
Na+ via NDCBE and pendrin as well as secrete K+ via BK channels [13]. These cells contribute to 
acid-base homeostasis as well as influencing Na+, Cl-, and K+ transport in the CD, and are 
hormonally regulated [13].  
1.1.6.2 Transport in Principal Cells 
Reclamation of Na+ in the principal cells is predominantly mediated by ENaC on the apical surface, 
driven by the low intracellular concentration gradient generated by the NKA on the basolateral 
surface. K+ excretion is mainly through the ROMK channels. Additional K+ channels, including a 
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two-pore domain K+ channel (TWIK), voltage-gated K+ channels ERG and KCNQ1, and inward-
rectifier K+ channels Kir4.1 and Kir5.1, have been identified in unique polarized domains within 
the CD; TWIK, ERG, and KCNQ1 are apical while Kir4.1 and Kir5.1 are basolateral, but their 
function in K+ regulation in the CD has yet to be determined [12]. Apical Cl- transport is mediated 
by the cystic fibrosis transmembrane regulator (CFTR) and extruded through a ClC Cl- channel 
family member, as well as moving paracellularly through tight junctions [15]. Also, essential to 
hormonally regulated transport in the CD are the AVP-sensitive aquaporin channels (AQP2) that 
increase water reabsorption from the lumen. 
A number of different stimuli control Na+, K+, and water transport in the principal 
collecting duct cells, including aldosterone, AVP, insulin, endothelin, angiotensin II, nitric oxide, 
bradykinin, and ATP [12, 15]; however, the focus of this dissertation is on the impact of 
aldosterone signaling on a protein-protein interaction to alter Na+ transport, so the introduction 
will focus on RAAS and the effects of aldosterone in principal cells. 
1.1.7 Renin-Angiotensin-Aldosterone-System 
As mentioned above, renin is released after macula dense cells sense a drop in NaCl concentrations 
or blood volume. Thisinitiates a hormonal cascade known as the renin-angiotensin-aldosterone-
system (RAAS), whose purpose is to maintain arterial pressure and extracellular fluid volume. 
Enzymatically active renin encounters the liver-secreted, pro-peptide angiotensinongen in vascular 
circulation and cleaves it into angiotensin I. Angiotensin I is then further cleaved by angiotensin 
converting enzyme (ACE) in the lung to its active form, angiotensin II. After binding to 
angiotensin receptors, which are G protein-coupled receptors, angiotensin II has a number of 
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functions, including potent vasoconstriction, cell proliferation, increased renal Na+ reabsorption, 
inhibition of renin release, and stimulation of aldosterone release from the zona glomerulosa of the 
adrenal glands [16]. Circulating aldosterone then stimulates a number of changes to increase Na+ 
in the distal nephron. 
Upon entering the cell, aldosterone interacts with the mineralocorticoid receptor (MR), 
which translocates into the nucleus and functions as a transcription factor, both classically through 
direct interaction with DNA steroid response elements, and atypically through indirect effects of 
protein-protein interactions [17]. The aldosterone response is generally separated into two phases, 
the early (with 1-6 hrs) and late (after 6+ hours), and instigates both genomic and non-genomic 
changes. Early-phase aldosterone-regulated proteins increase transcription of signaling 
transduction proteins such as the serum-glucocorticoid kinase (Sgk-1), resulting in post-
translational changes in channels and other pathway associated proteins [17, 18]. Late-phase 
aldosterone regulation induces increased expression of larger proteins, such as ENaC subunits 
[17]. Collectively, these changes result in increased Na+ retrieval, and indirectly increase water 
reabsorption to increase extracellular fluid volumes and blood pressure. 
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Figure 1-2. Renin-Angiotensin-Aldosterone-System. Low luminal NaCl and/or fluid volume 
triggers renin release from the macula densa cells (pink). Renin then cleaves the liver synthesized 
pro-peptide, angiotensinogen, to angiotensin I in the circulatory system. Angiotensin I is converted 
to Angiotensin II by ACE in blood vessels, predominantly in the lungs. Angiotensin II targets a 
number of different tissues, including cells in the adrenal gland that release the mineralocorticoid 
hormone, aldosterone. Aldosterone then interacts with the mineralocorticoid receptor in the distal 
nephron (yellow) to increase Na+ retention. 
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1.1.7.1 Non-genomic Regulation of Aldosterone via miRNAs 
In addition to genomic, transcriptional changes, aldosterone-regulated microRNAs (miRs) play a 
role in fine tuning the cellular response to aldosterone by inducing changes at the translational 
level [19, 20]. These short, noncoding pieces of RNA are initially transcribed as primary-RNA or 
pri-miR hairpin structures that are cleaved in the nucleus into a precursor-RNA or pre-miR. The 
pre-miR is then translocated to the cytoplasm where it interacts with protein machinery that 
reduces it to an active ~23-nucleotide RNA double strand, and is then associated with a miR 
silencing complex [19, 21]. This silencing complex targets the guide miR to bind to untranslated 
mRNA, typically the 3’-untranslated region, which results in degradation of the mRNA, and 
protein expression levels are reduced due to the reduction in translation [21]. Our lab discovered 
a number of miRs whose expression changes in response to aldosterone [20, 22]. The expected 
outcome is that if a miR is upregulated, it would likely reduce the expression of a protein/s involved 
in reducing Na+ transport, whereas expression of miR’s targeting positive regulators of Na+ would 
be decreased following aldosterone stimulation, allowing an increase in the expression of those 
proteins. 
Using a luciferase reporter assay as well as inhibiting miRNA expression, our lab identified 
the scaffolding protein, ankyrin G (AnkG), as an mRNA target of miRs that are down-regulated 
following aldosterone stimulation [20]. This resulted in the verification of AnkG as a novel, 
aldosterone-stimulated regulator of ENaC-mediated Na+ transport in principal CD cells. The focus 
of this project was to determine the mechanism by which AnkG increases vectorial Na+ transport 
in these cells. The following introduction sections will further examine the structure and function 
of ENaC, AnkG, and NKA. 
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1.2 EPITHELIAL SODIUM CHANNEL 
The epithelial Na+ channel (ENaC), is an amiloride-sensitive Na+ channel in the ENaC/DEG 
(degenerin) family of ion channels that is found in a number of epithelia, including kidney, colon, 
lungs, sweat and salivary ducts, and is a critical target of aldosterone stimulation [23-29]. 
Originally cloned from rat colon, renal ENaC is a heterotrimer comprised of α-, β-, and λ-subunits, 
which are encoded by SCNN1A, SCNN1B, and SCNN1G, respectively [24, 28, 29]. Some tissues 
also express a δ-ENaC subunit, encoded by SCNN1D, but it is not expressed in mouse and rat [30]. 
ENaC is the rate-limiting step for apical Na+ entry in the aldosterone sensitive distal nephron, 
where it plays a critical role in blood pressure homeostasis [24-29, 31]. ENaC activity is modulated 
by protein-protein interactions, post-translational modifications, ionic concentrations, shear stress, 
and proteolytic cleavage [32]. This diverse set of regulatory mechanisms demonstrates the 
physiological significance of the 2-5% of Na+ reabsorbed by ENaC in the distal nephron.  
1.2.1 ENaC and Disease 
The importance of ENaC for homeostatic blood pressure control is demonstrated by both gain-of 
and loss-of-function mutations in ENaC subunits, which cause two hereditary diseases, Liddle’s 
Syndrome and pseudohypoaldosteronism type I (PHA-1). First identified in 1963 by its namesake, 
Liddle’s syndrome presents clinically as severe hypertension and hypokalemia, with minimal 
aldosterone secretion [33, 34]. Liddle’s syndrome is caused by gain-of-function mutations in the 
β- and λ-ENaC, which result in excessive Na+ reabsorption in the distal nephron due to an increased 
number of channels present at the apical membrane, whose greater residence time likely increases 
their cleavage state and therefore open probability [26, 27, 31, 35-38].  
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In contrast, PHA-1 presents as severe salt-wasting in early infancy with hyponatremia, 
hyperkalemia, and high plasma aldosterone levels [39-41]. Now recognized as three different 
subtypes, PHA type 1 is caused by loss-of-function mutations in ENaC subunits, which reduce 
ENaC activity [42-44]. This reduction in activity causes less Na+ to be reclaimed, while less K+ is 
excreted, stimulating aldosterone secretion both through high K+ levels and low extracellular 
volume as the body attempts to reestablish ionic homeostasis. 
Beyond these monogenetic diseases, which clearly indicate the importance of proper ENaC 
function to control blood pressure, ENaC has also been implicated as a potential modifier of cystic 
fibrosis severity by helping to regulate the airway surface liquid (ASL) height and mucocilliary 
clearance [45-47]. In fact, global αENaC knock out mice die within 40 hours of birth from fluid 
filled lungs [48]. ENaC is proposed to play a role in mediating the ASL height, with greater Na+ 
transport through ENaC reducing ASL height [45]. In patients with cystic fibrosis, the ASL height 
and viscosity is reduced, impairing the lungs’ ability to clear particulates and pathogens, which 
causes inflammation and infection [45]. This impaired respiratory function is the main cause of 
morbidity among cystic fibrosis patients. 
1.2.2 ENaC Biophysical Properties 
Four key functional parameters define ENaC. Firstly, it is extremely selective for Na+ or Li+ 
compared to K+, preferring Na+ in a range of 100:1 to 1000:1, and is impermeable to larger cations 
[49]. Next, it is blocked by submicromolar concentrations of amiloride and amiloride analogs [49]. 
ENaC gating is also largely voltage-insensitive; that is, changes in the membrane potential does 
not dramatically impact ENaC Na+ transport. Lastly, ENaC has slow gating kinetics in the 
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transition between open and closed states. ENaC is electrogenic, so its activity can be measured 
using electrophysiological methods at the single channel, single cell, and tissue levels. The 
components contributing to total ENaC current are the conductance, open probability and the 
number of channels present. ENaC conductance is mostly invariable, so tight regulation of this 
channel is directed by changing the number of channels present or changing the open probability 
of channels. The following sections will discuss the structural components that impact channel 
number and open probability, as well as the dynamic proteostasis of ENaC biosynthesis and 
degradation. 
1.2.3 ENaC Subunit Structure 
To date, ENaC has not been crystallized; however, another DEG/ENaC family member, the acid 
sensing ion channel (ASIC1) has been successfully crystallized, elucidating likely structural 
components of ENaC. The ASIC1 channel forms a trimer from three identical subunits, whereas 
renal mammalian ENaC forms functional channels from the trimerization of α, β, and λ subunits 
[32, 50, 51]. The three ENaC subunits, α, β, and λ, are predicted to be structurally similar despite 
sharing only 30-40% sequence homology [32]. The subunits all have intracellular N- and C-
termini, two transmembrane spanning domains (TM1 and TM2), and large extracellular domains 
[32, 51]. The cytoplasmic N- and C-termini contain protein interaction motifs and sites for post-
translational modification of ENaC such as phosphorylation, palmitoylation, and ubiquitylation 
[52-58]. The transmembrane domains form the channel’s pore and selectivity filter [59], and the 
extracellular domains influence channel activity through proteolytic cleavage, ion interaction, and 
response to mechanical stress [60-62]. 
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Figure 1-3. ENaC Structure. Each ENaC subunit has cytosolic N- and C-termini, two α-helical 
transmembrane domains, and a large extracellular domain. The stars in α- and λENaC denote the 
locations of the proteolytic cleavage sites, while the stars in βENaC are the approximate location 
of an open probability mutation and the site of a putative AnkG binding motif that will be discussed 
later. 
 
1.2.4 Cytoplasmic Domains 
The intracellular N- and C-terminal domains of the ENaC subunits have many distinct functions. 
They can affect biosynthetic channel assembly, channel gating, channel number, subcellular 
localization, exocytosis, and endocytosis [27, 63-66]. Furthermore, the intracellular domains are 
not highly conserved among subunits, potentially allowing differential regulation of the subunits 
even though it is generally believed that they assemble into heterotrimers in the ER [67]. 
Association with cytoskeletal proteins aids channel trafficking and activity, palmitoylation 
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influences channel gating, and phosphorylation events both direct and indirect, can enhance or 
inhibit ENaC function. One exception to this lack of conservation is a proline-enriched region 
(PPPxYxxL) in the C-termini of all three subunits, which resembles both the NPxY motif, which 
is essential for endocytosis in some proteins [68], as well as the YxxL hydrophobic internalization 
motif [27]. Currently known as the PY-motif, these amino acid residues are essential for regulating 
internalization of ENaC, and mutations here are known to cause Liddle’s syndrome by disrupting 
ubiquitination, and therefore internalization[33, 35, 57]. 
1.2.4.1 Ubiquitination of ENaC 
After identification of mutations in the β- and λ-ENaC C-termini association with Liddle’s 
syndrome, experimental studies found that loss of this region or mutations within the conserved 
PPPxYxxL-motif increased ENaC activity [37, 38]. Using heterologous expression of truncated 
subunits in Xenopus oocytes, Snyder, et.al. determined that loss of the C-termini did not impact 
open probability, rather the increase in ENaC activity following truncation or missense mutation 
in this region resulted in an increased number of channels at the surface [69].  
Due to its similarity to the NPxY and YxxL motifs, it was hypothesized that changes here 
prevented internalization of the channels, but the affiliated proteins were not discovered until 
Staub, et.al. used the yeast-2-hybrid technique to identify Nedd4 as a protein binding to the PY-
motif [70]. It was later established that Nedd4-2, rather than Nedd4 is the predominant regulator 
of ENaC, and behaves similarly to the earlier experiments done with Nedd4 [71-73]. Nedd4 is an 
E3 ubiquitin ligase that is expressed in the collecting duct [74]. E3 ubiquitin ligases transfer 
ubiquitin groups to lysine residues in target proteins. Addition of multiple ubiquitin groups (poly-
ubiquitination), classically targets proteins for degradation by the lysosome or proteasome, 
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whereas mono-ubiquitination is typically affiliated with protein internalization. Co-expression of 
Nedd4 with ENaC in Xenopus oocytes demonstrated that Nedd4 reduced ENaC current in a dose 
dependent manner by reducing ENaC surface expression, and increased ENaC internalization rates 
[75]. Furthermore, the Liddle’s syndrome mutation, β-Y620A, abrogated the effect of Nedd4 
expression strongly supporting its role in internalization of ENaC through the PY-motif [75]. 
Nedd4 binds to the PY-motifs of ENaC subunits through 3 WW motifs, resulting in the 
ubiquitination of ENaC subunits at several lysine residues [57, 70]. ENaC can be either mono- or 
poly-ubiquitinated, but the specific effects of these modifications and where they take place 
intracellularly has not yet been determined [66]. To complicate matters further, there is an 
additional set of proteins know as deubiquitinating enzymes, or DUBs, that remove ubiquitin 
groups from targeted proteins, allowing additional control of the cellular fate of the targeted 
protein. One DUB, UCH-L3, can de-ubiquitinate ENaC, and pharmacological inhibition of this 
DUB reduces ENaC current by reducing the number of channels at the surface, further 
demonstrating the regulated control of ENaC internalization by ubiquitination [76]. UCH-L3 
increases Na+ transport by augmenting ENaC recycling [76]. The adaptable ubiquitination state of 
ENaC is an essential post-translational control of Na+ handling in the distal nephron. 
1.2.4.2 Phosphorylation Events and ENaC Function 
Phosphorylation of ENaC can both potentiate and reduce ENaC activity depending on the location 
of the phosphorylated residue. Initial studies of in vivo ENaC phosphorylation in Madin-Darby 
canine-kidney (MDCK) cells at a basal state or with aldosterone or insulin stimulation found that 
both the β- and λ-ENaC subunits were phosphorylated at a basal state, and that phosphorylation 
increased with stimulation [77]. This study further determined that the phosphorylation sites were 
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located in the C-termini of both β- and λ-subunits [77]. Two of the first sites to be identified were 
β-T631 and λ-T623 (human), which were both substrates of the extracellular regulated kinase 
(ERK) [52]. This post-translational modification resulted in a decrease in ENaC activity due to a 
greater association with Nedd4-2 [52]. Additional work from Shi, et al., identified β-S623, β-S631, 
λ-T630, and λ-T599 (human) as additional phosphorylated sites, with β-S631 and λ-T599 being 
substrates of casein kinase II (CK2), while the remaining sites were acted upon by an undetermined 
kinase [78]. Soon thereafter, β-S633 was established as a G-protein coupled receptor kinase 2 
(Grk2) substrate [79]. Of additional interest was that phosphorylation here as well as at β-S631 
augmented ENaC activity, likely through an unknown intermediary protein that reduced Nedd4-2 
association and Na+ feedback inhibition [54, 79, 80]. 
Indirect phosphorylation events also play critical roles in regulating ENaC activity. In 
response to aldosterone stimulation, the serum glucocorticoid kinase (Sgk1) expression is rapidly 
increased [81]. Sgk1 is a major coordinator of aldosterone signaling, and increases both ENaC and 
NKA Na+ transport. The increase in ENaC activity is a result of Nedd4-2 being inactivated through 
phosphorylation by Sgk1 [81] . The interaction between Nedd4-2 and Sgk1 is moderated via 
association with the regulatory protein, 14-3-3 [82, 83]. Aldosterone stimulation increases Sgk1 
expression as well as phosphorylation of Nedd4-2, which in turn increases 14-3-3 binding to Nedd-
2, preventing its association and ubiquitination of ENaC [66, 82, 83]. The end result is that fewer 
channels at the surface are ubiquitinated and internalized, resulting in increased surface channel 
expression. 
The other major indirect kinase regulation of ENaC is initiated by AVP signaling, which 
increases levels of protein kinase A (PKA) and cAMP. The stimulation by cAMP mobilizes a 
unique pool of intracellular ENaC to be rapidly exocytosed from a regulated recycling pool into 
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the apical membrane [84]. This compartment of channels is distinct from channels in a non-
regulated constitutive recycling pathway [84]. 
1.2.4.3 The Impact of Palmitoylation on ENaC Subunits 
Cys palmitoylation is a reversible addition of 16 carbon fatty acid palmitate to Cys residues in 
proteins that aids protein trafficking and subdomain targeting [85]. It is catalyzed by 
palmitoyltransferases, also known as DHHC proteins [85]. β-ENaC is palmitoylated at β-C43, β-
C557, while λ-C33 and λ-C41 are modified in λ-ENaC (mouse ENaC) [55, 56]. Elimination of β- 
and λ-ENaC palmitoylation reduces activity without reducing surface expression by decreasing 
the channel open probability. This reduction may be a result of disturbing the hydrophobic α-helix 
transmembrane residues associating with the plasma membrane [55, 56].  
1.2.4.4 Cytoskeletal Interactions and ENaC 
Mobility, targeting and stability of channels are all potential roles for ENaC’s association with the 
dynamic cytoskeleton. Researchers have been investigating the role of the cytoskeleton to 
associate with and modify ENaC before the channel was cloned, and was simply known as the 
amiloride-sensitive channel [86-88]. Initial studies found the amiloride-sensitive channel co-
segregated with cytoskeletal proteins actin, fodrin (now known as spectrin), and ankyrin in 
differential detergent extraction, and had limited lateral mobility, suggesting these proteins were 
having a stabilizing effect on ENaC at the membrane [87]. Studies have found that small actin 
filaments activate the channel, whereas competitive inhibition for actin binding by filamin or the 
G-actin binding DNAse1 reduce channel activity [86, 89]. Additionally, disruption of microtubule 
networks prevents a mucous-dependent increase in channel number in frog skin and disrupts ENaC 
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membrane insertion in mpkCCD cells, implying that the microtubule network may be a key player 
in ENaC exocytosis [84, 88]. Some early studies even suggest that ENaC targeting to the apical 
membrane is enhanced by an association between α-ENaC and α-spectrin through proline-rich 
SH3 binding domains in both proteins [90]. Continuing along this research avenue, Zuckermann, 
etal. found that ENaC and α-spectrin were in a macromolecular complex with apical protein 
Xenopus (Apx, now known as Shroom1), and this association is required for functional expression 
of ENaC in oocytes. Reduction of Shroom1 expression resulted in fewer ENaC channels at the 
surface rather than an alteration to the open probability [91, 92].  
Most research involving ENaC and the cytoskeleton has focused on how various attributes 
of actin, such as its state of polymerization and remodeling following PKA stimulation, impacts 
ENaC. This is due, in part, to the apical channel association with the dense cortical actin network 
that helps maintain the integrity of the apical surface in renal cells, and also because PKA 
stimulation further enhanced the increase in channel open probability seen when ENaC was treated 
with short actin filaments [93]. Actin effects on the channel take place through association with 
the C-terminus of the α-subunit, as truncation of this domain abrogated the increase in ENaC open 
probability from channels in planar lipid bilayers [86, 94, 95]. Additionally, the cortical actin 
associated protein, cortactin, reduces ENaC activity by reducing open probability via a link to the 
Arp2/3 complex [96]. 
More recent work has focused on discovering novel proteins involved in membrane-
transport-cytoskeleton interactions [22, 96-99]. The importance of small G-proteins, such as 
RhoA, Rac1, and Rab11, to modulate the cytoskeleton and influence ENaC are being increasingly 
realized [96-102]. It is clear the cytoskeleton is inextricably linked to ENaC function, and new 
 21 
players will likely keep emerging as we understand more about the dynamic associations between 
ENaC and the cytoskeleton. 
1.2.5 Transmembrane Domains 
The two-pass, α-helical transmembrane domains of the ENaC subunits are essential for pore 
formation, Na+ selectivity, gating, and amiloride sensitivity. Based on comparison to the 
crystallized ASIC1, it is likely that the TM2 helices of α-, β-, and λ-ENaC line the interior of the 
pore, while the TM1 helices form an outer ring facing the plasma membrane [51, 103]. This theory 
is strengthened by previous mutagenic analysis that localize the selectivity filter and amiloride 
binding site to residues in TM2, and as well as cysteine modification accessibility assays, which 
assessed accessibility of methanethiosulfonate regents to native and introduced cysteine residues 
within the pore [51, 103-107]. 
A key feature of ENaC’s pore region is its strong selectivity of Na+ and Li+ over K+, and 
inability to transport larger ions [49]. By selectively mutating amino acid residues in the TM 
segments, researchers identified a Gly/Ser-X-Ser sequence in all three subunits that confer Na+ 
selectivity, and alterations to these residues increased K+ transport or permitted transport of larger 
ions [106, 108, 109]. Located one helical turn above the selectivity filter at α-S583, β-G525, and 
λ-G537 (mouse) are the residues required for amiloride binding [105]. Mutations of the β and λ 
sites abrogates amiloride binding, while alterations to the α site has a less dramatic effect. Another 
site of interest in the pore region in the TM2 of theENaC subunits is a conserved residue which 
can alter gating. In our following experiments, we will be using the site found in the βENaC 
subunit. Addition of large side chains at β-S518 (mouse) results in a channel that is “locked” in a 
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constitutively open conformation; in other words, the channel is open nearly 100% of the time 
[110]. Figure 1-3 shows a representative single channel trace of WT ENaC open probability 
compared to the locked ENaC open probability, modified from Snyder, et al. 2000 [111].  
 
 
Figure 1-4. Representative single channel trace of a WT ENaC compared to the constitutively 
open “locked” ENaC. 
1.2.6 Extracellular Domains 
Each ENaC subunit has a large extracellular domain of approximately 450 amino acids located 
between TM1 and TM2. This domain can be broken down into several regions, namely two β-
sheet domains termed the β-ball and palm, as well as peripheral domains formed by α-helices, 
commonly known as the finger, thumb, and knuckle [51, 103]. In keeping with the hand anatomy 
comparisons, the linkers to the TM1 and TM2 segments are also known as the wrist region [51, 
103]. The extracellular domains are integral to ENaC activation via proteolytic cleavage, 
extracellular ion concentration sensing, and mechanosensitivity. 
1.2.6.1 Proteolytic Cleavage and ENaC Activation 
The finger regions of the extracellular domains of the α- and λ-subunits of ENaC have functionally 
relevant cleavage sites that are acted upon by both intracellular and extracellular proteases. 
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Proteolytic cleavage activates the channel by increasing its open probability. The initial step of 
proteolysis by serine proteases take place in the trans-Golgi network (TGN), where furin and 
potentially other proteases cleave α-ENaC at α-R205 and α-R231 and λ-ENaC at λ-R143 (mouse), 
although a pool of channels that escapes this proteolytic step has also been found at the plasma 
membrane suggesting an additional pathway that has yet to be elucidated (Fig. 1.3) [112, 113]. 
The λ-subunit is also further cleaved at the basic λ-RKRK186 tract by extracellular proteases such 
as prostasin or kallikrein [114-116]. Mutational analysis of these sites as well as treatment with 
protease inhibitors reduces channel activity substantially, suggesting cleavage is essential for 
ENaC activity, indeed, uncleaved channels have open probabilities of less than 0.1, whereas full 
cleaved subunits have an open probability approaching 1.0 [60, 112, 117-119]. Full cleavage of α- 
and λ-ENaC releases 26-residue and 43-residue peptides from α- and λ-ENaC, respectively [51, 
60, 117]. Over expression of these peptides can reversibly inhibit ENaC activity by reducing ENaC 
open probability, and studies by Carattino, et al. and Passero, et al. have identified the 8 amino 
acids in α-ENaC and 11 amino acids in λ-ENaC located at the finger-thumb interface responsible 
for this inhibition [118-120]. The likely functional implication of these cleavage events is a 
structural conformational change allowing the channel to exist in a more energetically favorable 
open state. 
1.2.6.2 Na+ Feed-back Inhibition and Self-Inhibition  
ENaC is regulated both by intracellular and extracellular Na+ concentrations, which are known as 
feed-back inhibition and self-inhibition, respectively, and take place over minutes to hours 
(feedback inhibition) or within seconds (self-inhibition) [66]. Both mechanisms involve the 
proteolytic state of the channel. With feed-back inhibition, increased cytosolic Na+ reduces both 
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channel number and ENaC cleavage, thereby reducing Na+ influx [121]. With self-inhibition, the 
magnitude of inhibition is dependent on the presence of the inhibitory tracts, that is, fully cleaved 
channels exhibit minimal Na+ self-inhibition compared to uncleaved or partially cleaved channels 
[51, 122]. ENaC Na+ self-inhibition is likely caused by conformational changes to the channel 
following Na+ binding to site/s within the extracellular domains; however, the location of these 
domains is still uncertain [51].  
1.2.6.3 Mechanosensing 
Luminal transporters throughout the nephron are subject to variable tubular flow rates and 
hydrodynamic stress, and several ENaC family members are mechanosensitive ion channels,  and 
ENaC activity is also modulated by shear stress. This mechanosensitivity has been demonstrated 
by increased Na+ transport in Xenopus oocytes heterologously expressing ENaC and subjected to 
variable bath perfusion rates, as well as increased Na+ flux in rapidly perfused, isolated rabbit 
CCDs [62, 123]. The rapid time course associated with increased ENaC Na+ transport following 
stimulation by laminar shear stress makes it more likely to be a result of a change in ENaC open 
probability rather than an alteration to the number of surface channels. Studies by Karpushev, et 
al.. and Carattino, et al.. examined potential role of the actin cytoskeleton and membrane lipid 
composition, respectively, but found neither significantly impacted ENaC activation by shear 
stress [98, 124]. In 2012, Shi, et al. reported that elimination of portions of the wrist domain, the 
interface between the extracellular domain and TM domains could alter the response to both shear 
stress and extracellular Na+ concentrations [125]. These results imply that ENaC mechanosensing 
results from conformational changes in response to flow, rather than by membrane deformation or 
tension associated with cytoskeletal adhesion. 
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1.2.7 ENaC Proteostasis And Trafficking 
To maintain stable levels of ENaC expression (proteostasis), there is a constant flow of new 
channels being synthesized and delivered to the plasma membrane, channels undergoing recycling 
to and from the membrane and endosomes, and channels being internalized and targeted for 
degradation. Figure 1.5 illustrates the different pathways associated with ENaC proteostasis. 
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Figure 1-5. ENaC Trafficking. ENaC subunits are co-assembled in the ER and undergo 
additional processing such as proteolysis and complex glycosylation in the Golgi. Improperly 
folded channels are degraded by the proteasome. Channels are then trafficked to endosomes or the 
plasma membrane. Some endosomes are regulated by cAMP following AVP stimulation. Channels 
at the surface are targeted for internalization by ubiquitination by Nedd4-2 and are either recycled 
or targeted for degradation to late endosomes and then the lysosome. Phosphorylation of Nedd4-2 
by Sgk1 results in its association with 14-3-3, and reducing its ability to target ENaC for 
internalization. NKA on the basolateral membrane generates the low cytosolic Na+ concentration 
driving Na+ entry through ENaC. Lys = lysosome, Prot = proteasome, LE = late endosome, RE = 
recycling endosome, Ub = ubiquitination. 
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ENaC subunits are believed to be translated and co-assembled in the ER, as studies in 
heterologous expression systems have found that newly synthesized channel half-life in increased 
and proteasomal degradation is decreased when all three subunits are expressed together [57, 126]. 
ENaC translation seems to be very inefficient in heterologous expression systems, with a majority 
of subunits being degraded by the proteasome [126]. All three subunits undergo core glycosylation 
in the ER before transport to the Golgi where they undergo complex glycosylation processing and 
furin cleavage [113, 126]. A subset of ENaC channels bypass the Golgi and are present as 
immaturely-glycosylated, uncleaved channels, but little is known about this alternative processing 
pathway [113]. 
Following Golgi export, the channels are either transported to the plasma membrane or 
maintained internally in intracellular vesicles. There appears to be at least two distinct pools of 
channels; one subset resides in an ENaC specific subapical compartment that responds to cAMP, 
while the other represents channels undergoing constitutive recycling and/or degradation [84]. The 
cAMP-regulated pool of channels play a key role in AVP signaling. Channels in cAMP-regulated 
vesicles are rapidly exocytosed following stimulation by AVP, allowing rapid reabsorption of Na+ 
[67, 84, 102].  
Relatively little is known about the various intracellular compartments through which 
ENaC moves during its membrane insertion and recycling, but our understanding is growing as a 
number of apical transport proteins have been described to interact with ENaC. We can also make 
inferences from what we know about apical trafficking of other proteins in polarized epithelial 
cells to postulate about ENaC trafficking. The asymmetrical nature of epithelia presents a unique 
challenge for cells that must define and maintain unique microdomains that are subjected to very 
different environments. Cellular trafficking machinery includes adaptor proteins, vesicle docking 
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and fusion proteins, endosomal sorting complexes, tethering molecules, cytoskeletal proteins, 
small GTPase proteins (Rho, Rac and Rab family members), molecular motors, and more. While 
there are some examples of sorting at earlier stages, more apical sorting seems to occur around the 
TGN or later via distinct endosomal compartments [127]. The small GTPase family members are 
often used to distinguish between different intracellular compartments, and have roles in 
reorganizing the cytoskeleton in addition to regulating trafficking. After internalization, apical 
proteins are targeted to an early apical endosome. After this they are transported to a Rab8-positive 
common recycling endosome, a Rab11-apical recycling endosome, or late endosomes that go on 
to form multi-vesicular bodies that fuse with the lysosome for degradation [127]. 
ENaC has been reported to interact with several small GTPases, including Rab4, Rab11, 
Rab27, and Rho [98, 99, 128-131]. Rho has been shown to activate ENaC by increasing membrane 
density [97]. Rab4, Rab11 and Rab27 can also increase or decrease ENaC activity, potentially via 
control of vesicle formation, vesicle fusion, or association of vesicular cargo with motor proteins 
[128-131]. It is likely that ENaC internalized from the surface moves through early and sorting 
endosomes following the internalization signal of ubiquitination by Nedd4-2. Some channels are 
de-ubiquitinated and recycled back to the membrane, whereas channels that remain ubiquitinated 
are moved through late endosome and multi-vesicular bodies, to eventually be degraded by the 
lysosome [102]. 
Tight regulatory control of ENaC is essential for proper physiological function, and takes 
places at many places, from transcription and translation to trafficking events and self-modulating 
structural components. Further understanding of its function will lead to a greater understanding 
of physiological Na+ handling.  
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1.3 NA+K+-ATPASE IN THE KIDNEY 
While ENaC is the rate-limiting step for Na+ entry in the collecting duct, this transport would not 
take place without the electrochemical driving force of the low intracellular Na+ concentration. In 
the collecting duct (and many other regions of the nephron), the physiological work horse behind 
this concentration gradient is the Na+K+ATPase (NKA), also known as the Na+ pump. NKA is a 
transporter found in all mammalian cell types [132], which is responsible for setting up the low 
Na+/high K+ intracellular concentrations found in most cells [132]. After hydrolyzing an ATP 
molecule, the Na+ pump transports 3 Na+ ions out of the cell and 2 K+ ions into the cell. This 
asymmetric stoichiometry is electrogenic and contributes to the intracellular negative potential 
difference of about 2mV. The NKA is essential for a number of cellular functions, including 
establishing the electrochemical potential across cell membrane, maintaining osmotic 
homeostasis, and providing a driving force for secondary active transport [132].  
In the kidney, the NKA is comprised of α, β, and γ subunits that oligomerize to form a 
transporter that catalyzes the active transport of ions (Fig. 1.6) [133-135].  The α subunit of the 
NKA is the major pore forming component of the transporter, and contains the catalytic domain 
responsible for ATP hydrolysis [132, 134]. The β subunit acts as a molecular chaperone, is 
essential for proper membrane targeting and may also regulate channel open state stability [132, 
134, 136]. The γ subunit is an ancillary subunit with variable tissue distribution, that can decrease 
the Na+ pump’s affinity for Na+ and K+, and increase NKA’s affinity for ATP [133]. The α-1 and 
β-1 isoforms are found throughout the nephron, whereas the γ subunit isoforms, γa and γb, have 
differential expression along the nephron [133, 135]. The γa isoform is located in the proximal 
tubules (PCT), medullary thick ascending limb (mTAL), cortical collecting ducts (CCDs) and, 
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macula densa, whereas the γb is only found in the PCT, mTAL and cortical thick ascending limb 
(cTAL) [135, 137]. 
 
 
Figure 1-6. Na+K+ATPase structure. NKA in the CD is comprised of three subunits, the pore-
forming α-subunit which is also responsible for ATP catalysis, the β-subunit, which aids in 
trafficking, and γa-subunit, which helps confer ATP sensitivity. 
 
Within the tubules, NKA is localized to the basolateral surface of the polarized epithelia 
[138], where it creates the intracellular Na+ concentrations that drive secondary active transport. 
In the PCT, this allows apical Na-dependent co-transporters to reclaim solutes such as glucose, 
bicarbonate, amino-acids, and phosphate from the glomerular filtrate. Further down the nephron 
in the mTAL, DCT, and CD, the NKA provides the ionic equilibrium needed for proper absorption, 
secretion, and paracellular transport of ions such as Na+, K+, Ca2+, Mg2+, and Cl- [138]. 
In the distal nephron, NKA is regulated by aldosterone, insulin, intracellular Na+, 
extracellular K+, as well as a number of kinases, intracellular signaling pathways, and the 
cytoskeleton [139]. This regulation is essential to respond to changes in dietary Na+, K+, and fluid 
intake. Corticosteroids and insulin acting through the glucocorticoid receptor, mineralocorticoid 
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receptor, or the insulin receptor instigate signaling cascades, which have both short and long term 
regulatory effects. Short term changes include increased exocytosis of intracellular Na pumps, 
increased Na+ affinity, and alterations to the kinetics of ATP catalysis, while long term effects 
involve increased transcription and translation of NKA [139]. Hormone-triggered signaling events 
impacting the NKA work through a number of kinases, including PKG, PKC, and PKA [139, 140]. 
Lastly, components of the cytoskeleton, including spectrin, actin, adducin, and ankyrin have been 
observed to interact with the NKA [139]. 
1.4 ANKYRINS 
1.4.1 Discovery of Ankyrins 
Ankyrins were first identified from studies in 1980 looking at the cytoskeleton or “ghosts” of 
erythrocytes [141].These cytoskeletal ghosts resulted from detergent extraction of erythrocytes 
which left a cytoskeletal scaffolding that could be viewed by light microscopy and maintained the 
basic structure of the erythrocyte. At this time, spectrin had already been identified as the spectral 
peripheral membrane protein located on the cytoplasmic side of erythrocyte ghosts, which was 
believed to play a role in the meshwork supporting the structure of the plasma membrane. This 
study discovered a protein associated with the intracellular plasma membrane that also bound 
tightly to spectrin [141]. This protein was identified and named ankyrin for its ability to anchor 
membrane proteins such as transporters and cell adhesion molecules to the spectrin cytoskeleton 
[142, 143]. 
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Four years later, a nonerythroid ankyrin was isolated from brain [144, 145]. This brain ankyrin is 
the first example of a membrane-associated protein capable of also binding to tubulin [145]. By 
1991, it was established that the erythrocyte and erythrocyte-related ankyrin (ankyrinR) and brain 
ankyrin (ankyrinB) were encoded by separate genes. AnkyrinB had 2 mRNA isoforms, one which 
encoded a polypeptide with a molecular weight around 220kDa, while the other’s protein product 
had a molecular weight of about 440kDa [146]. This paper also acknowledged that the current 
ankyrin nomenclature was insufficient to identify the potentially different genes and splice variants 
.     
Although there was sufficient proteomic evidence to determine there was another ankyrin 
beyond ankyrins R and B, the protein we now know as ankyrinG, or giant ankyrin since it was the 
440 or 480 kDa ankyrin found in brain, was not characterized until 1995[147]. Following the 
isolation of ankyrinG cDNA, a number of papers went on to discover and characterize several 
different tissue specific isoforms [148-150]. Finally, the field had consolidated the ankyrin 
nomenclature, with ANK1 encoding erythrocyte ankyrinR (AnkR), ANK2 encoding the broadly 
expressed ankyrinB (AnkB), and ANK3 encoding the giant and generally expressed ankyrinG 
(AnkG) isoforms. 
1.4.2 Ankyrins and Disease 
All three ankyrins have been implicated in different disease states, demonstrating their 
physiological significance [151]. AnkR has been linked to hereditary spherocytosis [152], AnkB 
has been linked to an inherited cardiac arrhythmia known as Ankyrin B syndrome [153], and 
several genome wide association studies have recently linked AnkG to bipolar syndrome [154-
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156]. Additionally, AnkB and AnkG have been established as secondary effectors in CRASH 
syndrome [157, 158], neonatal diabetes [159], and Brugada syndrome [160, 161]. In these cases, 
a mutation in another protein disrupting ankyrin binding results in disease. 
1.4.2.1 Hereditary Spherocytosis 
HS is one of the most common inherited red cell membrane disorders, and is caused by 
abnormalities in proteins regulating membrane-cytoskeleton association and stability [162]. Red 
blood cells in patients with HS have abbreviated life spans due to splenic retention and increased 
phagocytosis. Patients typically have hemolytic anemia, splenomegaly, and increased free 
bilirubin levels. Mutations in ANK1 are the most frequent cause of hereditary spherocytosis, and 
account for nearly 50% of all HS cases (HS) [162, 163]. The mutations in ANK1 typically cause 
missense, nonsense, frame shift and splicing changes, that decrease ANK1 mRNA; however, 
mutations linked to HS have also been found in the promoter region of ANK1, which likely also 
impact mRNA levels [152]. Overall, the net effect from these mutations leading to HS seems to 
be a reduction in total AnkR protein. A reduction in AnkR leads to uncoupling of the β-spectrin 
affiliated cytoskeleton from transmembrane proteins in the lipid bilayer. This causes loss of cell 
surface area, increased cell sphericity and decreased red blood cell flexibility, eventually leading 
to premature destruction of the deformed erythrocytes [162]. 
1.4.2.2 Ankyrin B Syndrome 
While initially labeled type 4 long-QT syndrome (LQTS) [164], this atypical LQT arrhythmia 
syndrome has more recently been renamed sick sinus syndrome with bradycardia, or “ankyrin B 
syndrome[153].” Ankyrin B syndrome presents with ventricular repolarization abnormalities, 
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sinus node bradycardia, and atrial fibrillation, which if untreated, can lead to sudden cardiac death 
[164, 165]. Depending on the mutation present, however, phenotype severity can vary widely 
[166]. Mutations in ANK2 (AnkB) result in mislocalization of the inositol triphosphate receptor 
(IP3R), NKA, and NCX, which cause abnormal intracellular Ca2+ dynamics, that in turn results in 
arrhythmia [167]. 
1.4.2.3 CRASH Syndrome 
After it was discovered that mutations in the neural cell adhesion molecule, LICAM, cause X-
linked hydrocephalus, MASA syndrome, agenesis of the corpus collosum, and certain forms of X-
linked spastic paraplegia, these syndromes were reclassified as CRASH syndrome [157, 158]. 
CRASH is an acronym for Corpus collosum hypoplasia, Retardation, Adducted thumbs, 
Spacticity, and Hydrocephalus [158]. Over 80 mutations in LICAM have been linked to disease 
with varying phenotype severity, depending on their functional effect on the LI protein [157]. Of 
these mutations, there are 2 located in the cytoplasmic domain that fall within a highly conserved 
AnkB binding domain [168]. These mutations disrupt LI-AnkB interactions and demonstrating the 
role of AnkB as a secondary effector in disease. Furthermore, the AnkB knockout mouse exhibits 
many characteristics of CRASH syndrome as well as loss of LI protein from axons [169].  
1.4.2.4 AnkB, KATP, and glucose homeostasis 
While KATP channels are found in many tissues, they have been most thoroughly studied in the 
pancreas, where they function as a metabolic blood glucose sensor. KATP channels are composed 
of the pore-forming Kir6.x-type subunits and sulfonylurea receptor (SUR) regulatory subunits, and 
mutations in both the Kir6.x and SUR encoding genes (KCNJ11 and ABCC8) have been linked to 
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diatbetes mellitus and hyper-insulinemia syndromes [170]. In 2004, a screen of permanent 
neonatal diabetes identified a missense mutation in Kir6.2, E322K, located in a conserved AnkB 
binding motif [159]. Later, experiments testing the membrane targeting of the Kir6.2 C-terminal 
domain found that this mutation had aberrant membrane trafficking, which was a result of loss of 
association with AnkB [171]. Interestingly, this mutation also caused a significant decrease in ATP 
sensitivity, suggesting AnkB plays a role in both membrane localization as well as channel 
function [171]. This association again demonstrates the role of AnkB in disease through secondary 
interactions.  
1.4.2.5 Bipolar Disorder 
Bipolar disorder (BD), previously known as manic-depressive illness, is a mental health disorder 
marked by alternating periods of elated and energized (manic) behavior and sad or hopeless 
(depressed) behavior. BD has both environmental and genetic components. Recently, several 
large-scale genome wide association studies in different populations have linked several SNPs in 
ANK3 (AnkG) to BD [154-156, 172]. Of note is that all of these SNPs fall within intronic regions; 
and their effects on AnkG expression and protein structure have yet to be elucidated. A recent 
study evaluated the effect of AnkG knockdown in the hippocampal dentate gyrus of mice [173]. 
The researchers found that mice with reduced AnkG expression had marked behavioral changes. 
More interestingly, they found that administration of a pharmalogically relevant does of lithium, 
the clinical standard of BD treatment for over 60 years, abrogated the behavioral effects of AnkG 
knockdown [173]. Further research is needed to determine the pathology underlying these ANK3 
SNPs in BD.  
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1.4.2.6 Brugada Syndome 
The voltage-gated channel, Nav1.5, encoded by SCN5A, is responsible for the fast depolarization 
phase of the cardiac action potential. Mutations in SCN5A have been linked to both gain-of-
function (LQTS3) and loss of function (Brugada Syndrome, dilated cardiomyopathy, and sick 
sinus syndrome) arrhythmia diseases. One Nav1.5 missense mutation, E1053K, falls within a 
conserved AnkG binding motif, similar to the E322K mutation in Kir6.2. Research from Vann 
Bennett’s group established that this mutation disrupted Nav1.5-AnkG association and reduced 
Nav1.5 surface expression in cardiomyocytes [160]. This is yet another example of ankyrins 
functioning as a secondary effector in disease. 
The broad range of organ systems impacted by ankyrin dysfunction or dissociation of 
ankyrin linkage, from brain to heart to pancreas to the circulatory system, demonstrates their 
physiological significance and diverse functions. The overarching mechanism behind these 
pathologies, however, seems to be aberrant localization of associated transmembrane or 
cytoskeletal binding partners. These diseases indicate that ankyrins have roles in either protein 
trafficking, microdomain maintenance, or both. Additional research into the underlying 
mechanisms involving ankyrins and their associated proteins will further elucidate the unique and 
diverse physiological roles of these widespread proteins. 
1.4.3 Ankyrin Domains 
All three ankyrin family members, R, B, and G, possess 4 major domains that allow them to 
interact with integral membrane proteins and the cytoskeleton as well as target them to specialized 
locations in polarized cells. These domains are the membrane binding domain (MBD), the spectrin 
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binding domain (SBD), the death domain (DD), and the C-terminal domain (CTD) (Fig. 1.7 and 
1.8) [174, 175].  
1.4.3.1 Membrane Binding Domain 
The N-terminal MBD is comprised of 24 ankyrin (ANK) repeats that interact with and bind a 
diverse range of transmembrane proteins, including channels, transporters, cell adhesion 
molecules, and endocytic machinery. These 24 repeats are further divided into 4 smaller domains 
(D1, D2, D3, and D4), each containing 6 repeats [176]. The ANK repeat is one of the most common 
sequence motifs in eukaryotes, and can mediate interactions involved in signal transduction, 
inflammatory response, vesicular trafficking, cytoskeleton integrity, cell cycle regulation, and 
transcriptional regulation [177].  
Each ANK repeat has a 33 amino acid primary sequence, which in tertiary form begins 
with a hairpin-like β-sheet followed by two anti-parallel α-helices, and ends with a loop that 
transitions into the next repeat [176-178].  In the case of the MBD, the 24 ANK repeat is believed 
to form superhelical spiral or solenoid-like shape [176, 179]. Interestingly, this structure has 
spring-like properties and will properly refold after being deformed [179]. A study using atomic 
force microscopy found that the ANK elasticity was proportional to the number of repeats, with 
greater repeats having greater force compliance [179]. This property has led to some speculation 
that ANK repeats may confer mechanosensing properties to their affiliated protein. Recently, work 
from Zhang, et al. demonstrated this mechanosensing capability of the ANK repeats by examining 
the ANK repeat domain of a confirmed mechanosensing Drosphila TRP channel. Removal of this 
domain eliminated channel sensitivity to mechanical perturbation, and transfer of the domain to a 
typically voltage-sensing channel allowed the channel to respond to mechanical stimulation [180]. 
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One of the remarkable characteristics of the ANK repeat is its ability to bind such a diverse 
range of proteins. This is in part because the primary amino acid sequence can vary significantly; 
the motif is defined by its tertiary structure, rather than its primary sequence, which allows greater 
variability and potentially greater specificity for individual proteins within distinct repeats [176-
178]. Additionally, the ANK repeats can bind proteins at both the inner and outer “groove” 
surfaces, and the curvature of the repeats themselves may confer substrate specificity as well [176].  
The unique assets of the ANK repeat motif, from its superhelical spiral shape, nano-spring 
biophysical properties, and primary amino acid sequence multiplicity, convey the MBD with its 
broad and diverse binding capabilities. Without these qualities, ankyrins would lack the ability to 
play significant roles in such a variety of physiological settings. 
1.4.3.2 Spectrin Binding Domain 
The centrally located SBD contains 3 conserved domains, 2 ZU5s and an UPA domain, which 
align as ZU5-ZU5-UPA[181]. The ZU5 domain, named for zona occludens-1 and unc5 proteins, 
is roughly 90-110 amino acid residues long. The UPA domain is found in unc5, PIDD, and 
ankyrins and has a β sandwich-like structure. The ZU5-ZU5-UPA is believed to form a 
supramolecular structure within the ankyrin protein [181]. β-spectrin binds ankyrin in the first ZU5 
domain through both electrostatic and hydrophobic interactions [182].  
Two mutations in the SBD of AnkB (DAR976AAA, A1000P) that disrupt the AnkB-β2-
spectrin interaction have been previously described [183]. The DAR999AAA and A1024P 
mutations of conserved residues in AnkG have also been shown to disrupt AnkG-β2-spectrin 
binding [184]. Studies in AnkB+/- cardiomyocytes determined that β2-spectrin requires AnkB for 
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proper localization, but AnkB still targets to its specific microdomains in the absence of spectrin 
binding, and preserves IP3R localization [183]. Loss of the AnkG-β2-spectrin interaction in 
epithelial cells; however, resulted in reduced lateral cell heights, suggesting that while AnkG can 
probably localize to the plasma membrane independently, its cytoskeletal interactions are 
important for lateral membrane assembly [184]. 
1.4.3.3 Death Domain 
The DD was originally discovered in Fas antigen and type I tumor necrosis factor (TNF) receptor 
as a critical domain for Fas mediated cell death transduction [185]. The DD is part of a superfamily 
of domains that have diverse cellular functions in addition to being critical for apoptosis. In AnkG, 
the core DD is composed of 6 α-helices and 3 310-helices, which are considered an α-helix 
intermediate conformation [186]. The hAnkG-DD shares 63% sequence identity with hAnkB-DD 
and 56% with hAnkR-DD; however, the sequence identity between hAnkG-DD and the canonical 
Fas-DD is less than 20% [186]. To date, little research into the function of the ankyrin DD has 
been undertaken. A yeast-2-hybrid screen of AnkG’s DD identified Fas and several TNF receptor 
family members as potential interacting proteins [187]. This paper went on to show that over 
expression of AnkG constructs in MDCK cells were sensitive to rapid Fas-mediated apoptosis only 
if the construct contained the DD. This Fas-stimulated apoptosis took place after 4 hours of Fas 
incubation [187]. Lastly, the authors showed that ankyrin (they do not specify which) and Fas are 
upregulated within 3 hours following kidney ischemia-reperfusion injury [187]. Additional studies 
are needed to more fully understand the functional role of ankyrin’s DD. 
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1.4.3.4 C-terminal Domain 
Also referred to as the regulatory domain when in combination with the DD, the CTD domain is 
highly divergent among ankyrin family members. For comparison, the MBD, SBD, and DDs of 
hAnkG and hAnkB are 74%, 68%, and 59% homologous, respectively, while their CTD domains 
have less than 11% amino acid sequence identity [188, 189]. Circular dichroism of the AnkB CTD 
domain, suggests it is a mostly flexible unstructured domain [190], although it has an AnkB-
specific amphipathic α-helix [189]. Scanning mutagenesis and yeast-2-hybrid experiments 
identified intra-molecular interacting residues, suggesting that the C-terminus folds to form inter-
domain interactions between the MBD and the CTD domain [190]. Mutational analysis of the 
amphipathic α-helix, also identified residues essential for AnkB function [189]. Mutations 
disrupting both the intra-molecular interaction and the formation of the C-terminal α-helix failed 
to rescue IP3R localization in AnkB+/- cardiomyocytes [189, 190]. 
Cardiomyocytes express high levels of both AnkB and AnkG; however, these family 
members are both targeted to highly specific regions within cardiomyocytes and interact with 
unique protein sets. AnkB co-localizes with IP3R, ryanodine receptors (RyR), and SERCA2, 
whereas AnkG co-localizes with voltage-gated channels at the intercalated disk and T-tubules. A 
clever study using AnkB and AnkG c-terminal chimeras found that the CTD of AnkB is 
responsible for localization to the regions containing IP3R, RyR, and SERCA2 [188]. 
Additionally, in order to rescue IP3R and RyR localization in AnkB-/- cardiomycytes, the ankyrin 
construct required MBD, SBD, and CTDs, but the MBD and SBD domains of AnkB and AnkG 
were interchangeable so long as the AnkB CTD was preserved [188].  
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Figure 1-7. AnkR and AnkB Isoforms and Domains. The canonical, small, and large AnkR and 
AnkB isoforms. Different domains are shown in the legend. MBD = membrane binding domain, 
DD = death domain, SBD = spectrin binding domain, CTD = C-terminal domain, aa = amino acid. 
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Figure 1-8: AnkG Isoforms and Domains. The canonical, small, and large AnkG isoforms. 
Different domains are shown in the legend. MBD = membrane binding domain, DD = death 
domain, SBD = spectrin binding domain, CTD = C-terminal domain, aa = amino acid. 
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1.4.4 Ankyrin Isoforms 
Among ankyrin family members, there are a number of splice variants that contain specialized 
domains, and/or lack certain aspects of the above-mentioned domains. The various isoforms can 
be broken down into 3 categories, the canonical ankyrins, the small ankyrins, and the large 
Ankyrins, which are depicted in Figures 1.7 and 1.8 [191]. The next section will describe the 
various isoforms of AnkR/B/G and their localization.  
1.4.4.1 Canonical ankyrins (180-220 kDa) 
The canonical ankyrins contain all the afore-mentioned domains, namely, a 24 ANK repeat MBD, 
an SBD, a DD, and a CTD, and are roughly 180-220 kDa in size. AnkR is spliced into two 
canonical ankyrins, one around 215 kDa, and another at 186 kDa, and these AnkRs can be found 
in erythrocytes, skeletal muscle, and certain neurons in the brain [192-194]. The shorter form (186 
kDa) lack a portion of the CTD and has a higher affinity for both the anion exchanger, spectrin, 
and tubulin [193].  
AnkB is found in brain, heart, skeletal muscle, pancreas, lung, liver, and thymus, among 
others [192, 195-197]. For a long time, it was believed that AnkB expressed only one canonical 
isoform at a molecular weight of 220 kDa; however, a recent paper has gone on to describe two 
additional canonical isoforms, at molecular weights of 212 kDa and 188 kDa [196]. The 212 kDa 
form is lacking 3 ANK repeats in the MBD, has a larger SBD, and has a longer CTD that includes 
a binding site for obscurin [196]. The 188 kDa form has a truncated CTD that eliminates the 
obscurin binding site, and its expression level impacted NCX expression while the 212 kDa 
isoform did not [196]. The authors were able to create a 212 kDa specific antibody and found that 
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it detected the 212 kDa isoform in skeletal muscle and heart, but not brain, liver, or lung, unlike 
the 220 kDa form [196]. These results suggest we still have much to learn about the different 
ankyrin splice variants and their cellular functions. 
AnkG has the broadest expression of the ankyrin family members [198-201]. There are 2 
canonical AnkG isoforms, on that is 200-215 kDa, and another that is 190 kDa. The difference 
between the two isoforms is that the 190 kDa has a shorter CTD, and the larger form has a highly 
acidic alternative CTD sequence, sometimes referred to as epithelial insert C or the 195 amino acid 
insertion [198, 202, 203]. 
1.4.4.2 Small ankyrins (20-120 kDa) 
The small ankyrins are the most divergent of the ankyrin variants. Often they lack or have truncated 
MBDs, they can lack SBDs, they have altered CTDs, and frequently have unique start codons. 
AnkR has one small ankyrin form, which is expressed in skeletal muscle [204-206]. This 
isoform is 20-30 kDa in size and localizes to the sarcoplasmic reticulum in skeletal muscle [204, 
206]. This small AnkR has a novel first exon, with a unique 72 amino acid N-terminus that is 
predicted to form a transmembrane helix that acts as a membrane anchor [204, 206]. To date, no 
small ankyrin form of AnkB has been described.  
AnkG has a number of different small ankyrin forms with a broad range of domain swaps, 
tissue domains, and intracellular locations[148, 192, 199, 200, 203]. In skeletal muscle alone, 4 
small ankyrins have been described and named according to their molecular weight [199, 203]. 
AnkG107 lacks ANK repeats and has a novel 76 amino acid insertion in the CTD relative to the 
canonical AnkGs. AnkG109 is identical to AnkG107 with the exception of a 17/18 amino acid 
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insertion prior to the novel 76 amino acid insertion. The 17/18 amino acid insertion differs only in 
the presence of an additional n-terminal glutamine residue. AnkG128 lacks the MBD, has the novel 
76 amino acid insertion, and has an additional 195 amino acid insertion upstream of the 76 
insertion within the CTD. AnkG130 is identical to AnkG128, with the exception of the addition of 
the 17/18 amino acid insertion[199, 203]. A recent paper looking at alternative splicing of ANK3 
(AnkG) in the heart identified 2 new exons and 28 potential splice variants at the mRNA level 
[207]. While some of these splice variants were expressed at very low levels, many could be found 
throughout the heart. The various characteristics of the splice variants will not be described here.  
The last two small AnkGs that have been described are unique for their affiliation with 
particular intracellular organelles. One study found 2 small AnkG isoforms in macrophages, with 
molecular weights of 100 and 120 kDa. These AnkGs have unique N-termini, lack MBDs, and 
vary by insertion of the 195aa/insert C domain [198, 200]. Most interestingly, however, was the 
fact that both of these small AnkGs were found associated with lysosomes in the macrophages, 
rather than the plasma membrane[200]. The other small AnkG that has been shown to be associated 
with an intracellular organelle is AnkG119, which has been shown to associate with the Golgi 
apparatus [148]. This AnkG has a portion of the MBD, but only has 13 ANK repeats instead of 
24, has an intact SBD and DDs, and a truncated CTD [148]. Originally identified in MDCK cells, 
AnkG119 co-localizes with βIΣ-spectrin in the ER and Golgi and possibly in a subset of 
endosomes, and is postulated to play a role in Golgi-directed trafficking [148]. 
1.4.4.3 Large ankyrins (270-480 kDa) 
The large ankyrin family members all have MBDs, SBDs, DDs, and CTDs; however, these 
domains have insertions after the SBD, which are known as the tail and serine/threonine rich 
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domains. The large AnkB can be found in unmyelinated axons of neonatal brain, suggesting it may 
have a role in axogenesis, and has a molecular weight of 440 kDa [208, 209]. AnkB440 is identical 
to AnkB220, except that it has a 220 kDa tail insert that forms an unstructured domain between 
the SBD and DD [191, 209].  
There are two large AnkG ankyrins, AnkG270 and AnkG480, again named for their size 
in kDas [147]. These large ankyrins vary in their tail insert lengths (the 270 kDa has a shorter 
insert), and also have a novel 46 kDa domain that is enriched in serine and threonine residues [210, 
211]. Serine and threonine residue make up 35% of all amino acids in the domain [210]. This 
Ser/Thr rich domain has sequence similarity to mucins, and has a single O-linked N-
acetylglucosamine (O-GlcNAc) glycosylation modification [210]. While not required for proper 
targeting to the axon initial segment in neurons, this glycosylated domain is believed to prevent 
diffusion of the large AnkGs to other regions of the neuron.  
Overall, the incredible diversity of isoforms allows ankyrins to further diversify their 
binding partners and subcellular localizations. The following sections will more closely examine 
the physiological functions of AnkB and AnkG in a variety of different cell types. 
1.4.5 Ankyrin Function 
While initially described as a static, “anchoring” protein, recent research suggests ankyrins may 
also have dynamic roles in trafficking and formation of unique microdomains. AnkG expression 
in neurons is essential for the formation and maintenance of the axon initial segment, as loss of 
AnkG resulted in dendrite like projections rather than a proper AIS and loss of voltage-gated 
channels [212, 213]. In bronchial epithelial cells, MDCK cells, and collecting duct cells, loss of 
 47 
AnkG resulted in significant loss of lateral height, suggesting it may play a role in lateral 
membrane biogenesis and endocytosis [184, 214-216]. Additionally, loss of AnkG in 
cardiomyocytes, neurons, and epithelial cells results in improper targeting of a number of channels 
and transporters [160, 217-220]. AnkB is also critical for targeting channels and transporters to 
functional domains in the heart and other tissues, as loss of AnkB expression results in diffuse, 
improper localization [221-224]. Lastly, AnkG and AnkB may play a role in molecule transport 
by acting as a linker between molecular motor proteins kinesin-1 and dynactin and associating 
with the small GTPases RabGAP1L and Rab22 [225-227]. These results suggest that ankyrins 
have a diverse range of functions that may hinge on their interaction partners and cell type. In the 
next section, the role of AnkG in epithelia will be examined more closely. 
1.4.6 Ankyrins in Epithelia 
Thus far, the role of ankyrins in epithelia has primarily focused on AnkG’s effect on NKA, E-
cadherin and the ammonium transporter (RhBG), although new studies are currently emerging 
suggesting AnkG may also mediate renal Na+ and Mg2+ transport [22, 215, 228, 229]. Ankyrin 
may be important for targeting NKA and RhBG to appropriate microdomains, while AnkG on the 
lateral membrane promotes membrane integrity by preventing lateral endocytosis [215, 219, 230]. 
1.4.6.1 Ankyrin and NKA 
The first report of an association between the NKA and ankyrin dates back to 1987 [231], when 
W. James Nelson and Pamela Veshnock began investigating the interaction between cytoskeletal 
proteins and membrane proteins in non-erythroid cells. At the time, most studies investigating the 
functional significance underlying the association between structural proteins and membrane 
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proteins, such as the AE1 (Band 3), had been performed in erythrocytes [231, 232]. Since polarized 
epithelial cells had some of the same cytoskeletal proteins (ankyrin and spectrin (fodrin)), they 
hypothesized that there would be comparable functional membrane protein to cytoplasmic 
structural protein linkage in epithelial cells. They demonstrated the ability of NKA purified from 
canine kidney medulla and ankyrin purified from erythrocytes to cause electrophoretic mobility 
shifts in non-denaturing PAGE gels and characterized the binding of 125I-labelled erythrocyte 
ankyrin to NKA vesicles. This seminal paper set the foundation for the future studies looking to 
ankyrin as a potential structural and organizational component of polarized cells. 
In 1989, two studies found that the kidney ankyrin from Madin-Darby Canine Kidney 
(MDCK) cells and NKA co-sedimented in sucrose gradients [233, 234].NKA and the kidney 
ankyrin “analogue” co-localized in the basolateral membrane of renal proximal tubule cells, and 
ankyrin bound the α-NKA subunit in ~ 1 ankyrin to 4 NKA molar ratio [233, 234]. By 1990, it 
was known that ankyrin could be proteolytically digested into 89 kDa and 62 kDa fragments, which 
correspond to the ankyrin repeat domain and the spectrin-binding + C-terminal domains, 
respectively [235]. Research from Vann Bennett’s lab established that while the anion exchanger 
1 only bound the 89 kDa fragment, NKA could bind both the 89 kDa and 62 kDa fragments, and 
did so with less affinity than the anion exchanger [235]. Continuing this line of investigation, a 
study by Devarajan, et al., determined ankyrin binds to the 2nd and 3rd intracellular domains of α1-
NKA [236] and later established that a 25-residue “minimal ankyrin binding” sequence, found in 
the 2nd intracellular domain of NKA was the region of key association [237]. This binding motif 
differs substantially from the ankyrin binding motif that has been described for voltage gated Na+ 
and K+ channels [238]. It also is worth noting, that up until the paper by Zhang, et al., all of the 
NKA and ankyrin interaction research had been performed using erythrocyte (AnkR) ankyrin 
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rather than the predominant kidney ankyrin (AnkG) [237]. This was likely due to the relatively 
easy AnkR purification from abundant red blood cells [143], as well as initial confusion about the 
different ankyrin genes and isoforms and cross-reactivity of early ankyrin antibodies [146].  
The potential role of ankyrin tethering the NKA to the intracellular cytoskeleton in 
specialized polarized domains was further strengthened by immunological studies that found NKA 
expression levels paralleled expression of ankyrin and fodrin (β-spectrin), but not E-cadherin 
[229]. Early studies of kidney ankyrin initially describe it as being basolateral [229, 234, 239]; 
however, improvements in light microscopy resolution, recent transmission electron microscopy 
images of AnkG in kidney tubules [240], and large scale proteomics work [241] have demonstrated 
that AnkG is also associated with the apical membrane, suggesting it has multiple roles in polarized 
cells. 
Additional work from Jon Morrow’s lab went on to investigate the potential role of ankyrin 
on NKA trafficking. Their first paper from 1997, focused on the ability of a Golgi-specific AnkG 
isoform (AnkG119) they had recently identified to form a docking complex with βIΣ-spectrin and 
assist with cargo transport in the Golgi [242]. This study found that AnkG119 co-
immunoprecipitated with βIΣ-spectrin and a presumable Golgi-associated fraction of NKA; 
however, they did not specifically look at the effects of modulating AnkG119, rather they found 
that over expression of a βI-spectrin mutant construct disrupted localization of the endogenous 
Golgi ankyrin-spectrin skeleton and blocked ER-to-Golgi transport of the NKA. From this indirect 
evidence, they inferred that there is a spectrin-ankyrin-adaptor protein trafficking system (SAATS) 
that is involved in targeting and sorting proteins in the secretory pathway.  
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A second paper, from 2008, looked more directly at the potential ability of ankyrin to 
facilitate intracellular trafficking of NKA [230]. In MDCK cells expressing both AnkR and AnkG,  
they found that knock down of AnkR, but not AnkG resulted in accumulation of α1-NKA in the 
cytoplasm rather than appropriate targeting to the plasma membrane [230]. The presence of AnkR 
in kidney tubule cells has not been definitively established. Due to early cross-reactivity of the 
ankyrin antibodies, the erythrocyte ankyrin detected was most likely AnkG. Also, trace levels of 
erythrocytes in kidney tissue could easily contaminate RNA and proteomic samples. Furthermore, 
while the researchers did provide a Western blot showing the decrease in AnkR protein in the 
MDCK cells, they never showed its localization in MDCK cells, so whether it is  Golgi, plasma 
membrane, or cytosolically associated is still in question, and no other papers have made 
references to AnkR in polarized epithelial cells. Lastly, only AnkR and not AnkG had an effect on 
NKA plasma membrane targeting [230]. 
More recent studies have looked at the association of NKA and AnkB, and seem to provide 
more solid evidence of a functional relationship between AnkB and NKA, rather than the more 
basic biochemical associations and imaging colocalization. This suggests the possibility that 
AnkB, rather than AnkG is the key facilitator between NKA, the cytoskeleton, and other associated 
transporters. The first such study looked at AnkB in coordination with NKA and calcium signaling 
via the NCX1 and the IP3R in cardiomyocytes [223]. This work found that heterozygous AnkB+/- 
knock out mice had mislocalized NKA, NCX1, and IP3R, as well as elevated intracellular [Ca2+] 
transients [223]. 
A study from Liu, et al., addressed the potential role of AnkB to impact a ouabain sensitive 
signaling microdomain between NKA and the IP3R [243]. Following application of ouabain, the 
association between NKA and IP3R initiates slow calcium oscillations that control downstream 
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signaling pathways, such as activation of NF-κB. Additionally, AnkB has previously been shown 
to interact with IP3R [223]. The authors found that knock down of AnkB resulted in a significant 
reduction in calcium oscillations and reduced NF-κB activation, but had no impact on NKA surface 
expression or ion transporting function [243]. 
While biochemical analysis of ankyrin and NKA, such as co-immunoprecipitations and in 
vitro binding assays, as well as co-localization in certain tissues suggest that NKA and ankyrin 
interactions are functionally significant, research exploring the effect of different ankyrins on NKA 
transporter function in cells where both proteins are highly expressed is just beginning. The studies 
so far seem to implicate AnkB rather thank AnkG as the key modulator of NKA. Future research 
will hopefully further our understanding the functional role of NKA association with ankyrins. 
1.4.6.2 Ankyrin and the Ammonium Transporter RhBG 
Using a yeast-2-hybrid system, Lopez, et al. found that the C-terminal domain of the ammonium 
transporter RhBG could interact with portions of the AnkG and AnkB MBDs; however, only AnkG 
was colocalized with RhBG in rat kidney epithelial cells [219]. Disruption of the AnkG binding 
site resulted in mislocalized RhBG and impaired ammonium transport [219, 244]. This interaction 
was then shown to be an important complex, allowing association of the kidney AE1 with RhBG, 
which may have functional consequences for acid-base homeostasis maintenance in distal nephron 
intercalated cells [220]. 
1.4.6.3 Ankyrin and E-Cadherin 
In 2004, Kizhatil, et al. examined the role of AnkG in bronchial epithelial cells, and found that 
depletion of the 190kDa-AnkG using siRNA significantly reduced lateral membrane height. This 
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finding was recapitulated in MDCK cells as well as bronchial cells (HBE) and collecting duct cells 
in a global AnkG knockout mouse [184, 214, 215, 245]. Lateral membrane height could be rescued 
by reintroduction of AnkG, but not AnkB, and required the AnkG to have intact MBD, SBD, and 
CTD regions [184, 214]. Loss of the AnkG cytoskeletal binding partner, β2-spectrin, also 
phenocopied this result [214, 237]. Delving further into this effect, the authors found that cell-
adhesion molecule, E-cadherin, was a binding partner of AnkG and requires AnkG and intact 
microtubules in order to exit the TGN and traffic to the lateral membranes in HBE cells [246]. 
Furthermore, mutations impairing the E-cadherin-AnkG cytoskeletal link increased E-cadherin 
lateral mobility as determined by fluorescence recovery after photobleaching. Observation of E-
cadherin in an AnkG knockout mouse; however, revealed that E-cadherin still localized to lateral 
membranes, suggesting that there might be compensatory action from additional molecular 
partners [215]. Indeed, clathrin heavy chain expression was upregulated with AnkG knock down 
[215]. Using shRNA knock down and targeted mutagenesis, it was determined that both AnkG 
and clathrin cooperated for proper localization of E-cadherin, with clathrin mediating mis-sorted 
apical E-cadherin and AnkG by stabilizing lateral E-cadherin by restricting its lateral mobility and 
endocytosis [215].  
This prevention of lateral endocytosis was later proposed to be a more bulk effect of the 
AnkG-β2-spectrin cytoskeletal meshwork, rather than an E-cadherin specific function. AnkG is 
present in microdomains below the lateral membrane that have minimal colocalization with 
clathrin or clathrin cargos (transferrin receptor and low-density lipoprotein receptor) [216]. AnkG 
knock down results in bulk lipid uptake from the lateral surface which can be prevented by 
treatment with the clathrin-mediated endocytosis inhibitor, dynasore [247]. Lastly, the authors 
found that knock down of both AnkG and clathrin heavy chain prevented the loss of lateral 
membrane height with AnkG knock down alone, leading them to conclude that AnkG mediates 
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lateral membrane height through prevention of endocytosis [247]. These studies demonstrate that 
ankyrins have diverse functions that are still being uncovered. 
1.4.6.4 Ankyrin and ENaC 
The earliest suggestion of an ankyrin-ENaC interaction can be traced back to 1991, when Smith, 
et al. found that the amiloride-sensitive Na+ channel could co-immunoprecipitate with erythrocyte-
purified AnkR [87]. Despite this early association, the functional significance of this interaction 
was not more fully investigated for many years. This is likely due to the earlier studies that 
proposed renal ankyrin was basolaterally associated, and thus unlikely to modulate ENaC. More 
recent studies, however, have found evidence that AnkG is also found subapically in renal tubule 
cells [240, 241]. Transmission electron microscopy images of kidney tubules with AnkG specific 
antibodies have found that AnkG is associated with some apical endosomes [240]. Additionally, 
the 190kDa-AnkG isoform has been identified in an apical membrane proteomic screen of 
mpkCCD cells [241]. These findings reinforce the potential of AnkG to interact with ENaC. In 
2014, Edinger et.al. determined that AnkG expression is regulated by aldosterone-sensitive 
miRNAs [20]. The 3’ untranslated region of AnkG (Ank3) has over 50 putative miR binding sites, 
and of these, 12 are potential binding sites for 3 miRs (miR-1983, miR-335-3p, miR-290-5p) 
whose expression decreases following aldosterone stimulation [20]. Inhibition of these miRs using 
interfering locked nucleic acids resulted in an increase in AnkG expression. Additionally, AnkG 
expression reduced via siRNA resulted in a blunted the increase in Na+ transport following 
aldosterone stimulation [20]. Essentially, what is likely happening is that following aldosterone 
stimulation, these miRs are down-regulated, which results in more AnkG being translated. AnkG 
then augments Na+ transport through association with Na+ channels or transporters such as ENaC 
and NKA in mCCD cells. 
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1.4.7 Hypothesis 
The aim of this study was to determine the mechanism by which AnkG increases Na+ transport in 
mCCD cells. First, I verified AnkG expression in mouse and rat kidney as well as in our mCCD 
cell line. Then I established that AnkG is affecting Na+ transport through ENaC rather than NKA, 
and that it does so by increasing apical ENaC expression. Since AnkG has been shown to be 
essential for both proper protein localization and endocytosis, I systematically examined the 
different components of ENaC proteostasis, namely, internalization, apical delivery, cAMP-
regulated recycling, and constitutive recycling to establish the intracellular transport mechanism 
underlying AnkG regulation of ENaC, as shown in Figure 1-9. Lastly, I investigated a potential 
site of ENaC-AnkG interaction in the C-terminus of βENaC. This research presents an important 
foundation for further understanding aldosterone-regulation of AnkG and cytoskeletal and 
trafficking regulation of ENaC, which in turn better our understanding of Na+ transport in kidney 
physiology. 
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Figure 1-9: ENaC Proteostasis. Different aspects of ENaC trafficking where AnkG may be 
influencing Na+ transport are shown. In the following experiments we will determine whether 
AnkG alters ENaC internalization, recycling, and insertion. 
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2.0  RESULTS 
2.1 INTRODUCTION - MECHANISM OF ANKG-ENAC INTERACTION 
Transport through ENaC is the rate-limiting step for Na+ reabsorption in the distal nephron. The 
amount of Na+ reabsorption through ENaC is determined by the number of channels at the apical 
membrane (N) and the open probability (Po) of those channels [248, 249]. Following a decrease in 
blood pressure or plasma Na+, stimulation by aldosterone increases Na+ reabsorption through 
ENaC by increasing both N and Po [250-252]. Aldosterone increases translation of ENaC and 
increases the expression of proteins that modulate ENaC density or activity. New protein 
modulators of ENaC activity are still being described that allow fine tuning of Na+ homeostasis 
critical for maintaining extracellular fluid volume [253-256]. 
AnkG is highly expressed in the kidneys, where it may help maintain transmembrane 
proteins in polarized domains; however, little is known about its hormonal regulation and how it 
interacts with ion transport proteins in the nephron [150, 198, 202, 228]. A number of different 
mechanisms have been proposed to describe how AnkG interacts with membrane channels and 
transporters. We investigated plasma membrane delivery, apical membrane residency time and 
alterations in ENaC internalization and degradation to assess the mechanism by which AnkG 
modulates ENaC activity and surface expression. Statistical significance in the figures is denoted 
as p-values <0.05 = *, <0.01 = ** , and <0.001 = ***. These experiments begin to define the 
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mechanism of AnkG’s interaction with ENaC and provide insight into how it may modulate Na+ 
reabsorption in the collecting duct. 
2.1.1 AnkG is expressed in the kidney in the proximal tubules, TAL, DCT, and CD 
AnkG is found throughout the nephron in varying abundance, with the exception of the glomeruli. 
Recent work from epithelial transcriptome at the NIH of rat kidney tubule segments has further 
elucidated the relative abundance of transcribed Ank3, and the likely AnkG isoforms associated 
with them [257]. Rat tubule segments were manually dissected and lysed, and RNA was isolated. 
Then the tubule segment specific reverse transcribed RNA was analyzed for abundance [257]. 
Figure 2.1 depicts the two isoforms, (190kDa-AnkG (isoform 1) and 220kDa-AnkG (isoform 2)), 
and their varying abundance along the nephron. Overall, isoform 190kDa-AnkG is transcribed in 
much higher levels than 220kDa-AnkG. Additionally, 190kDa-AnkG is most highly expressed in 
the TAL and the aldosterone-sensitive distal nephron, particularly the DCT and the CCD where 
Na+ modulating transporters, NCC and ENaC, reside. Figure 2.2 demonstrates AnkG expression 
in rat kidney tubules in both the cortex and medulla. In Figure 2.2C, AnkG is clearly expressed at 
the plasma membrane in TAL, DCT/CNT, and CD cells. In the TAL, AnkG seems most associated 
with the basolateral infoldings, whereas it is expressed at both apical and basolateral surfaces in 
DCT/CNT, and at the plasma membrane and more cytoplasmically diffuse in the CD. 
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Figure 2-1: AnkG mRNA expression in rat kidney. Relative abundance of AnkG transcripts 
along the nephron. Two AnkG isoforms are expressed in rat kidneys. Isoform 1 is more abundant 
and corresponds to the 190kDa-AnkG, while isoform 2 is the 220kDa-AnkG (See Fig.1.8). These 
data were generated from public domain transciptomic data from the Epithelial Systems Biology 
Laboratory at the National Heart, Lung, and Blood Institute [257]. 
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Figure 2-2: AnkG expression in the kidney. AnkG expression is shown in green and AQP2, a 
collecting duct marker, is shown in red. A) AnkG expression in the cortex. B) AnkG expression in 
the medulla. C) Magnified view of AnkG expression in the medulla. Glom = glomerulus, PT = 
proximal tubule, LH = thin loops of Henle, TAL = thick ascending limb, DCT = distal convoluted 
tubule, CD = collecting duct.  
 
2.1.2 AnkG is expressed at the plasma membrane in mCCD cells  
AnkG localization was determined by immunofluorescent confocal imaging. As shown in the z-
stack projection images in Figure 2.3 and 2.4, AnkG is localized at the plasma membrane as well 
as some intracellular punctae. The cortical actin ring was used to establish mCCD cell polarity.  
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Figure 2-3. AnkG expression in mCCD cells. Confocal z-stack images of mCCD cells with 
AnkG (green) and actin (red). The cortical actin ring was used to establish apical polarity, and it 
is shown in the middle panel. AnkG (right panel), is expressed at apical, lateral, and basal surfaces.  
 
We previously showed that AnkG expression is altered by aldosterone via a change in 
microRNA expression [20]. Figure 2.4 demonstrates the increase in AnkG expression following 
24 hours of 50nM aldosterone. Aldosterone stimulation also appears to result in greater plasma 
membrane association. 
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Figure 2-4. Aldosterone stimulation increases AnkG expression. AnkG is shown in green, ZO1 
staining in red, and nuclei in blue. A) Representative immunofluorescent image of unstimulated 
mCCD cells. B) Representative image of mCCD cells 24 hours after 50µM aldosterone 
stimulation. C) Summary of AnkG fluorescence intensity. Mean fluorescence signal for total 
cellular expression of AnkG from individual cells as defined by manually drawn regions of interest 
(ROIs). Cells were selected blindly from ZO1 staining, and signal from z-stack images were 
averaged. Aldosterone stimulation significantly increases AnkG expression (1.53 ± 0.04 vs 1.16 ± 
0.03, n>45, p<0.001).   
 
2.1.3 Low Na+ diets do not detectably impact AnkG expression in mouse collecting ducts 
To determine whether the increase in AnkG expression resulting from aldosterone stimulation seen 
in mCCD cells could be recapitulated in a mammalian kidney, we placed mice on low (aldosterone 
stimulation) or normal Na+ diets (control), and examined AnkG protein expression using IF. To 
generate aldosterone stimulated kidneys, mice were started for 7 days on a standard diet, then 
placed in metabolic cages to measure food and water consumption, feces and urine excretion, and 
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to collect urine. The mice were then switched to a low Na+ diet (Sodium Deficient Diet; Harlan 
Laboratories Inc., Frederick, MD) for 7 days, then placed in metabolic cages for 24 hours, after 
which point, kidneys were collected from the animals for downstream experiments. To measure 
CD specific AnkG expression, we outlined CDs (as determined by AQP2 staining) using ROIs and 
normalized the IF signal to the number of cells. We could not detect any changes in AnkG 
expression at the protein level (Fig. 2.5); however, it is possible that the changes seen in cells are 
too subtle to be detected using IF. 
 
 
Figure 2-5. AnkG expression in CDs of mice on low or normal Na+ diets. AnkG is shown in 
green and CDs were determined by AQP2 expression (red) A) Representative IF image of AnkG 
expression in kidneys from mice B) Summary of normalized AnkG expression in CDs of mice on 
low or normal Na+ diets. AnkG expression in CDs were determined by defining CD tubules as 
regions of interest (ROI) and then total fluorescence intensity was normalized to the number of 
cells/ROI. There was no significant difference in AnkG expression between conditions (N=3, 
n≥90). 
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2.1.4 Variable Na+ diets do not change AnkG expression in rat kidneys at either the whole 
kidney level or in CDs 
We also tested whether a high Na+ diet could impact AnkG expression levels in rat kidney sections 
generously provided by Alexander Staruschenko (Medical College of Wisconsin). Whole kidney 
AnkG expression was determined by normalizing the AnkG fluorescent signal to the nuclear 
signal. Collecting Duct specific expression was determined by defining CDs as ROIs and 
normalizing total signal to the number of cells per tubule. We did not detect any significant change 
in AnkG expression between low or high Na+ diets (N=5, whole kidney n≥35 image fields, CDs 
n≥40) (Fig.2.6). 
 
 
Figure 2-6. AnkG expression in rat kidneys on low or high Na+ diets. A) Representative image 
of rat kidney tubules with AnkG (green) and AQP2 (red) expression. B) Summary graph of AnkG 
fluorescence intensity of rats on low or high Na+ diets from whole kidney or CDs. No significant 
differences were detected. 
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2.1.5 AnkG expression alters vectorial Na+ transport  
To test if a change in AnkG expression altered ENaC activity, AnkG was knocked down (KD) or 
over expressed (OE) in mCCD cells and ENaC-mediated Na+ transport determined by short-circuit 
current (Isc) measurements in Ussing chambers. Reducing AnkG expression resulted in a 69 ± 2% 
(n=15) reduction in the amiloride-sensitive Isc, whereas over-expressed AnkG increased ENaC 
currents by 67 ± 11% (Fig. 2.7). The augmentation in ENaC current with AnkG OE could also be 
recapitulated in an epithelial cell line without ENaC (FRT cells, Fig.2.11) as well as by two-
electrode voltage clamp of Xenopus oocytes (Fig. 6.1). The continuity of this phenotype strongly 
suggests the validity of this association. 
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Figure 2-7. AnkG expression impacts Na+ transport in mCCD cells. A) Representative short-
circuit current (Isc) recordings of ENaC activity with control (black), AnkG KD (light gray) and 
OE (dashed, dark gray). 10 µM amiloride is added at the end of the recording to determine the 
ENaC-specific contribution of the current recordings. Control data represents either transfection 
of a non-specific siRNA for AnkG KD, or transfection of the GFP vector for AnkG OE. B) 
Summary of normalized Isc from several experiments. AnkG KD reduces ENaC current (0.31 ± 
0.06 vs 1.00 ± 0.03, n≥15, p<0.001), and AnkG OE increases ENaC current (1.67 ± 0.11 vs 1.00 
± 0.06, n≥12, p<0.001). 
 
2.1.6 Na+K+-ATPase (NKA) localization is unaffected by AnkG expression 
Previous studies have shown that all three ankyrin family members, AnkR, AnkB, and AnkG can 
bind to domains in NKA [202, 231, 237, 243, 258], and that AnkR expression is required for NKA 
targeting to the plasma membrane [230]. Since NKA is critical for establishing the electrochemical 
gradient that drives Na+ entry through ENaC, we wanted to verify that changes in vectorial Na+ 
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transport observed in Figure 2.7 were due to changes in ENaC activity at the apical surface rather 
than through indirect changes to the NKA localization or function. 
Using immunofluorescence labeling in polarized mCCDs, we determined that AnkG 
knockdown in mCCD cells did not impact basolateral targeting of NKA (Fig. 2.8). We observed a 
decrease in lateral height (6.2 ± 0.12µm vs 5.4 ± 0.14µm, n≥39, p-value <0.001) and an increase 
in cell width (7.9 ± 0.48µm vs 9.5 ± 0.43µm, n=30, p-value=<0.05) with AnkG knock-down (Fig. 
2.8B) which is consistent with previous studies of AnkG knockdown in epithelial cells [184, 214, 
215]. Additionally, consistent with an increase in cell width to compensate for decreased lateral 
height, capacitance measurements of apical and basolateral surface area confirmed that AnkG 
knockdown and over expression did not significantly alter total membrane surface area in the 
mCCD cells (Fig. 2.8C). 
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Figure 2-8. Effect of AnkG expression on Na+K+ATPase expression and cell dimensions. A) 
Representative projection image of α-NKA (green) in control or AnkG KD mCCD cells. White 
scale bars are 10µm. B) Lateral heights and cell widths were determined using line analysis 
software in Nikon Elements. In control cells, the average lateral height of mCCDs was 6.2 ± 
0.12µm, n=50, and the average cell width was 7.9 ± 0.5µm, n=30. In contrast, cells with AnkG 
knockdown had significantly shorter lateral heights of 5.4 ± 0.141, n=39, p-value<0.001, and 
significantly longer cell widths, (9.4 ± 0.4, n=30, p-value<0.05).  C) Summarized capacitance data. 
AnkG KD or AnkG OE did not impact the apical or basolateral surface area of polarized mCCD 
epithelial monolayers. 
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2.1.7 AnkG expression changes Na+ by modifying ENaC activity, but not NKA 
To test the impact of AnkG knock-down on isolated NKA and ENaC currents, we selectively 
permeabilized the apical or basolateral membranes of polarized monolayers, respectively in 
modified Ussing chambers to isolate each membrane domain. Using the ionophore nystatin, 
membrane permeablizations were carried out as described previously [84]. To verify 
permeabilization of the apical membrane, 10µM amiloride was applied to the apical surface to 
demonstrate the amiloride-sensitive current was eliminated. Membrane capacitance measurements 
performed concurrently with Isc recordings verified apical permeabilization due to the appearance 
of basolateral membrane capacitance. We observed a spike in Isc following apical 
permeabilization (Fig. 2.9A), the result of rapid influx of Na+ into cells from the higher 
extracellular concentrations. Within a minute the pump activity reached a plateau, at which point 
ouabain was added to determine the steady-state NKA activity. For basolateral permeabilizations, 
experiments were performed with a low-Na+ concentration Ringer’s solution in the basolateral 
chamber to provide a driving force for Na+ entry via ENaC when the NKA transport was eliminated 
as previously described [84]. Basolateral permeabilization was verified by application of 30µM 
ouabain, which did not significantly impact Na+ transport through ENaC (Fig. 2.9B). NKA activity 
and membrane surface area (Fig. 2.8 and 2.9) were unaffected by AnkG knock down; however, 
ENaC activity was significantly reduced (Fig. 2.9C), suggesting the that changes in Na+ transport 
seen in Figure 2.7 were due to changes in ENaC activity at the apical surface. 
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Figure 2-9. AnkG expression modulates ENaC, but not NKA. A) Representative current (black) 
and capacitance (gray) traces of apical membrane permeabilization. The spike in current activity 
following permeabilization is the result of the rapid influx of Na+. After reaching a steady state, 
apical permeabilization was confirmed with amiloride, and NKA current was determined by 
addition of ouabain. B) Representative current (black) and capacitance (gray) traces depicting 
basolateral permeabilization. ENaC current was determined by addition of amiloride, following 
confirmation of basolateral permeabilization with ouabain. C) Results of AnkG KD on isolated 
NKA and ENaC currents. AnkG KD did not alter NKA conductance; however, it significantly 
reduced ENaC current (0.57 ± 0.04 n=5 vs 1.00 ± 0.14 n=4, p-value<0.05). 
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2.1.8 AnkG does not alter whole cell ENaC expression levels in mCCD cells 
To test whether the increased AnkG altered endogenous whole cell ENaC expression, Western 
blots of cell lysates from mCCD cells in which AnkG was depleted or over-expressed were carried 
out. Knock-down of AnkG reduced total AnkG expression, but did not alter expression of the 
ENaC subunits or the α-subunit of NKA. Likewise, AnkG over-expression did not change 
endogenous AnkG, ENaC, or NKA protein levels (Fig. 2.10).  
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Figure 2-10. Altering AnkG expression does not impact total protein levels. A) Representative 
Western blots of total ENaC subunit expression with AnkG OE and KD relative to control. B) 
Summary graph of normalized densitometry from Western blots analyzing the expression levels 
of AnkG, ENaC and the NKA expression. AnkG KD reduced total endogenous AnkG expression 
levels (0.35 ± 0.10 vs 1.00 ± 0.12, n=5, p<0.001). AnkG OE and KD did not significantly affect 
the expression levels of any ENaC subunits, or NKA, or endogenous AnkG in mCCD cells. C) 
Representative Western blot showing expression of the GFP-tagged AnkG OE construct. The 
~60kDa band seen in the α-ENaC WB has been verified as non-specific using α-ENaC knockdown 
in mCCD cells. 
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2.1.9 AnkG does not impact ENaC open probability 
ENaC current is determined by the number and the open probability (Po) of the channels at the 
plasma membrane. As AnkG is linked to the cytoskeleton and actin binding to ENaC has been 
shown to alter channel Po, we next determined if AnkG’s regulation of ENaC activity was via a 
change in Po. In these experiments, we used Fisher Rat Thyroid (FRT) cells. Unlike mCCD cells, 
the FRT cells lack endogenous ENaC. Experiments utilizing ENaC mutations were all performed 
in FRT cells to exclude the contribution of endogenously expressed ENaC from WT channels that 
would be present in mCCD cells. FRT cells were transfected with wild-type α-, λ-, and βENaC or 
S518K βENaC. The βENaC mutant locks the channel in an open confirmation, resulting in a 
channel that has a Po close to 1 [110]. If AnkG altered ENaC Po, preventing this regulation by 
using the “locked” mutant would eliminate the increase in ENaC-mediated Na+ transport observed 
with AnkG over-expression. Over expression of AnkG in FRT cells increased total current of both 
WT (1.00 ± 0.03 vs 1.45 ± 0.05, n=44, p <0.001) and β-S518K (1.00 ± 0.09 vs 1.55 ± 0.11, n=11, 
p<0.001) ENaC. The percentage increase between WT AnkG OE and β-S518K AnkG OE was not 
significantly different (p-value =0.369) demonstrating that AnkG likely alters the number of 
channels to increase Na+ transport (Fig. 2.11). 
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Figure 2-11. AnkG does not alter Po in FRT cells. Summarized results of the effect of FRTs 
expressing WT or β-S518K (Locked) ENaC with AnkG. The locked ENaC has a Po of ~1, so a 
lack of effect would indicate that AnkG can alter Po. AnkG OE increases β-S518K current similarly 
to WT demonstrating that AnkG OE alters ENaC N at the membrane surface, rather than Po. 
 
2.1.10 AnkG increases surface expression of ENaC subunits in FRT cells 
After determining that AnkG likely does not alter Po in our expression system, we proceeded to 
examine ENaC surface expression. To do this, we expressed V5-tagged ENaC constructs with or 
without AnkG in polarized FRT cells, and biotinylated proteins on the apical surface. After cell 
lysis, equal amounts of protein were probed with anti-V5 antibody to create an ENaC enriched 
immunoprecipitate. These samples were incubated with streptavidin-conjugated magnetic beads 
to isolate the biotinylated apical fraction. Protein expression from the total lysate, 
immunoprecipitated fraction, and biotinylated fraction were then visualized by Western blot. 
Densitometry measurements were normalized to an actin loading control and then AnkG OE 
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samples were normalized to the control values. Interestingly, and dissimilar to the mCCD cells, 
AnkG OE increased total ENaC subunit expression. This phenomenon will be discussed more 
thoroughly in the discussion. In addition to an increase in total ENaC expression, AnkG OE also 
augmented the number of channels at the surface, even after accounting for the increased subunit 
expression. This supports our conclusion that AnkG expression alters Na+ by increasing the 
number of channels at the surface.  
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Figure 2-12. AnkG OE increases total ENaC protein and ENaC at the surface in FRT cells. 
A) Representative Western blots of FRT biotinylation experiment. The box enclosing a portion of 
the βENaC blot indicates a longer exposure. B) AnkG OE resulted in a significant increase in α-, 
β-, and λENaC subunit expression in a heterologous expression system relative to FRT cells 
transfected with a control plasmid (2.05 ± 0.58, 2.23 ± 0.29, and 1.77 ± 0.38, n≥3, p<0.001). 
Densitometry values were normalized to actin loading control and then to control plasmid values. 
Equal amounts of protein were immunoprecipitated to create an ENaC enriched fraction which 
was then probed with streptavidin to visualize surface ENaC expression. C) AnkG OE significantly 
increased βENaC and λENaC subunit surface expression (1.70 ± 0.03 and 1.40 ± 0.13, n≥3, 
p<0.01). Insufficient data prevented quantitation of αENaC as the surface expression of only the 
AnkG OE, but not the control could be reliably detected, thus it appears to also increase with AnkG 
OE. Surface expression was normalized to the immunoprecipitated, enriched ENaC fraction to 
account for the total protein increase resulting from AnkG OE. 
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Therefore, AnkG is expressed in the collecting duct, at both apical and basal membranes. 
Its expression in mCCD cells increases following aldosterone stimulation, and AnkG alters Na+ 
transport by increasing the number of ENaC at the apical surface, without affecting NKA. The 
mechanism behind this increase was not known. AnkG interacts with membrane channels and 
transporters in a variety of ways, including prevention of endocytosis and increasing interaction 
with motor proteins [215, 226]. We therefore investigated plasma membrane delivery, apical 
membrane residency time and alterations in ENaC internalization and degradation to assess the 
mechanism by which AnkG modulates ENaC activity and surface expression. 
2.1.11 AnkG does not affect internalization rates of ENaC 
To alter the number of channels at the plasma membrane, AnkG could regulate the rate of surface 
delivery, apical recycling, cAMP-regulated recycling, and/or removal of ENaC from the 
membrane. As mentioned in the introduction, ubiquitylation and internalization of ENaC is a well-
established means of reducing the number of ENaCs at the plasma membrane [57, 71]. To test 
whether AnkG was altering internalization rates, we incubated mCCD cells for 30 minutes with 
300mg/mL cycloheximide to block protein synthesis, and pre-stimulated the cells with 5µM 
forskolin to exocytose channels in cAMP-regulated recycling vesicles. We then measured the 
reduction in Isc over time as channels were internalized to constitutive recycling vesicles and/or 
targeted for degradation. After normalization to initial current, we found there was no significant 
difference in current decay rates with AnkG KD or OE (Fig. 2.13). 
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Figure 2-13. ENaC internalization rates following inhibition of protein synthesis. mCCD cells 
were pretreated with 300mg/mL cycloheximide and stimulated with 5µM forskolin, current decay 
was measured for 60 min, and 10µM amiloride was added to determine the ENaC specific Na+ 
current. A) Representative Isc trace of mCCDs treated with cycloheximide. B) Summary curves 
of normalized internalization currents. There is no significant difference between the conditions. 
  
The cycloheximide experiment, however, was less than ideal as cycloheximide could also 
be impacting expression of proteins essential to ENaC trafficking. We therefore tested if AnkG 
over expression reduced ENaC internalization rates. FRT cells expressing WT ENaC or a 
cleavage-resistant (CR, see methods for mutation sites) ENaC were co-transfected with GFP or 
AnkG, and subjected to an electrophysiological pulse-chase experiment. The CR ENaC mutations 
prevent cleavage by endogenous proteases, which keeps them in an inactive state (electrically 
silent) at the surface membrane [73]. CR channels can be activated by addition of an exogenous 
protease like trypsin in the apical compartment [112, 259]. This allowed us to activate a pool of 
channels at the membrane with a trypsin pulse (followed by trypsin washout), and observe the 
internalization of the active ENaCs as a measure of the reduction in current over time.  
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After 30-60 minutes of rundown we reapplied trypsin to determine whether inactive 
channels had been delivered to the membrane during the rundown period. Four conditions were 
analyzed, namely WT ± AnkG and CR ± AnkG. The WT ± AnkG traces were included to show 
the slower rate of internalization when the recycling pathway is intact. A sample trace of one such 
experiment comparing WT ENaC and CR ENaC is shown in Figure 2.14A, and a sample trace 
comparing CR ENaC control with CR ENaC AnkG OE is shown in Figure 2.14B. Introduction of 
the CR mutations did not change the AnkG phenotype on ENaC, namely increased ENaC current 
with AnkG OE (Fig. 2.14C). After normalizing to the initial current following trypsin activation 
(pulse), we plotted the average internalization curves of multiple experiments (Fig. 2.14D). The 
Isc rundown for WT ENaC were slower than those of the CR ENaC as contributions from the 
biosynthetic and recycling pools were not eliminated. However, while the apparent CR ENaC 
internalization rates were faster as expected, AnkG OE did not significantly alter Isc rundown. 
This suggests that AnkG was not altering the rate of ENaC endocytosis. 
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Figure 2-14. AnkG does not alter internalization rates of ENaC in FRT cells. A) 
Representative Isc traces of wild type (WT) and cleavage resistant (CR) ENaC expressed in FRT 
cells following trypsin activation, wash out, secondary trypsin activation, and amiloride block. CR 
ENaC is electrically silent until trypsin cleavage activates the pool of ENaC at the surface. 
Following removal of trypsin, the decay of current in the CR ENaC transfected FRTs gives the 
rate of internalization without contribution from channels being inserted into the membrane from 
biosynthetic pathway. B) Representative Isc trace of CR ENaC with or without AnkG OE. C) 
Summary of WT ENaC and CR ENaC Isc phenotypes. In FRT cells heterologously expressing 
ENaC and a control plasmid or AnkG, AnkG OE increased WT ENaC current (1.45 ± 0.05 vs 1.00 
± 0.02, n=45, p<0.001) and also increased the trypsin activated CR ENaC current (1.40 ± 0.16 vs 
1.00 ± 0.04, n=11, p<0.05). D) Average current decay curves of WT and CR ENaC with control 
or AnkG OE. WT ENaC decay rates are shown to demonstrate their slower rate due to contribution 
of channel insertion from the recycling and biosynthetic pathways. 
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2.1.12 cAMP-dependent ENaC recycling is not affected by AnkG expression 
Next, we looked at the effect of AnkG on ENaC trafficking in response to cAMP stimulation and 
stimulus washout. We previously characterized an intracellular ENaC pool, which is acutely 
inserted into the membrane in response to activation of cAMP [84, 260]. Using 5µM forskolin to 
repeatedly mobilize these vesicles, we measured the rates of ENaC insertion and removal as well 
as the relative percentage increase in current resulting from insertion of this pool of channels in 
control transfected and AnkG depleted mCCD cells. A representative trace is shown in Figure 
2.15A. After normalization to the initial current, we did not observe changes in either the 
percentage increase or rates of insertion following forskolin stimulation (Fig. 2.15B) nor any 
changes in the percentage decrease or rates of removal with AnkG knockdown (Fig. 2.15C). These 
data suggest AnkG is not altering the ENaC recycling through the cAMP-regulated pool. 
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Figure 2-15. ENaC cAMP-regulated recycling is not affected by changes in AnkG expression. 
A) Representative Isc traces of mCCD cells undergoing three rounds of 5uM forskolin stimulation 
and wash out. Forskolin increases intracellular levels of cAMP, which in turn results in the 
insertion of an intracellular pool of ENaC channels into the membrane. B) Summarized results of 
rate and percentage increase from initial current over time for mCCDs following forskolin 
stimulation. Data points are the averages of n=5 experiments, and are normalized to the initial 
current value of each experiment. There is no significant difference in the rate or relative 
percentage of channels inserted into the membrane. C) Summarized results of ENaC 
internalization following removal of forskolin. Data are normalized to the initial current of each 
experiment. There is no significant difference in the rate of removal or percentage of channels 
internalized (n=5). 
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2.1.13 AnkG increases the rate of ENaC membrane insertion 
To test whether AnkG increased the rate of ENaC delivery to the apical membrane we performed 
a variation of the electrophysiological pulse-chase described above using mCCD cells. First, we 
stimulated mCCD cells with forskolin to insert ENaC from the cAMP-regulated pool into the 
plasma membrane. We next irreversibly blocked all the channels at the surface using 25µM 
phenamil [261]. Following wash out of the inhibitor, any recovery of the Isc represents newly 
inserted ENaC to the apical surface from a blocker-inaccessible intracellular reserves, such as 
channels from the biosynthetic or non-cAMP-regulated recycling pathways. Increase in Isc was 
normalized to the initial (unblocked) value. A representative trace of the entire protocol is shown 
in Figure 2.16A, and a trace of the normalized recovery following phenamil block is shown in 
Figure 2.16B. After 30 minutes, the control traces had recovered to 15 ± 1.8% (n=20) of the initial 
starting current, whereas cells with AnkG knock-down recovered to 8 ± 2.8% (n=8, p<0.05) and 
cells with AnkG over-expression had recovered 24 ± 2.5% (n=9, p<0.01) of the starting current 
(Fig. 2.16C). These data demonstrate that AnkG increases ENaC surface delivery, likely either by 
increasing delivery from the biosynthetic pool or delivery from recycling intracellular ENaC 
stores. In addition, while the AnkG over-expressing cells recovered faster, the currents also trended 
to a plateau indicating a new steady-state was being reached with surface and intracellular pools. 
These experiments demonstrate that AnkG expression levels impact ENaC delivery to the apical 
membrane. 
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Figure 2-16. AnkG alters ENaC activity by increasing the rate of surface delivery in mCCD 
cells. A) Representative Isc trace of mCCD cell current recovery after 5 μM forskolin stimulation 
and block by 25 μM phenamil. Phenamil irreversibly blocks all channels at the surface, and once 
the phenamil has been removed, the amiloride-sensitive current that appears over time is the result 
of channels being inserted from the biosynthetic and non-cAMP-regulated pathway. Pre-treatment 
with forskolin inserts channels from the recycling pool into the surface, eliminating them as 
possible contributions to the recovery current. B) Current recovery plotted as a percentage of pre-
inhibited values over time. The rate and extent of recovery in AnkG OE cells is greater than control 
or AnkG KD mCCDs. C) percentage recovery summary demonstrated that after 30 min, 
significantly more channels were delivered to the surface with AnkG OE (24 ± 2.5%, n = 9; p < 
0.01) and significantly fewer channels with AnkG KD (8 ± 2.8%, n = 8, p value<0.05) relative to 
control (15 ± 1.8%, n = 20). 
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To verify this accelerated surface delivery, we examined ENaC appearance in the FRT cell 
model with CR ENaC. As previously shown in Fig. 2.14A and B, after the 30 min wash out period 
following the initial trypsin pulse, the second trypsin treatment was re-applied to determine the 
number of inactive channels that had been delivered to the plasma membrane. AnkG over-
expression increased the magnitude of the second trypsin pulse suggesting an increase in the 
number of channels delivered to the membrane relative to WT within 30 minutes (1.75 ± 0.16 vs 
1.00 ± 0.06, n=15, p<0.001) These data confirmed that AnkG increased ENaC membrane delivery 
relative to controls, but do not distinguish whether the increase in channel delivery was from 
channels being delivered from the biosynthetic pathway or from intracellular recycling pools. 
 
 
Figure 2-17. AnkG increases ENaC membrane delivery in FRT cells. A) Representative trace 
of CR ENaC with GFP (control) or AnkG OE. Following a 30 minute run down, cells were treated 
with a 2nd trypsin pulse to determine the number of channels delivered to the surface during that 
time period. B) Summary data of normalized currents from the 2nd trypsin pulse. AnkG OE 
increases ENaC surface delivery (1.75 ± 0.16, n=15, p<0.001) 
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To dissect these two possibilities, we repeated the CR ENaC trypsin pulse chase 
experiment with the addition of the Liddle’s mutation, P616L βENaC [36]. This mutation prevents 
ubiquitination and delays internalization of ENaC from the plasma membrane. These channels 
would therefore not have a significant contribution to a constitutive ENaC recycling pool and 
AnkG’s role in altering delivery to the surface from the biosynthetic pathway could be investigated 
in isolation from the recycling ENaC. Figure 2.17A depicts a representative trace of the CR 
Liddle’s ENaC trypsin pulse-chase experiment. The Liddle’s mutation significantly increased 
ENaC activity as expected, but not to the same extent as AnkG over-expression (Fig. 2.18B). 
Following the 30 minute run down, there was a limited response to the second trypsin pulse, and 
no significant difference in the number of channels delivered with control or AnkG OE Liddle’s-
mutant ENaCs (n=8, p=0.09) (Fig. 2.18B). These results demonstrate that the increase in current 
resulting from the second trypsin pulse in the CR ENaC experiments are predominantly from non-
cAMP-regulated recycling channels rather than channels being delivered from the Golgi through 
the biosynthetic pathway.  
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Figure 2-18. AnkG expression increases ENaC delivery in FRT cells by increasing recycling 
through the non-cAMP-regulated pathway. A) Representative trace of FRT cells expression CR 
ENaC in combination with a Liddle’s mutation, with or without AnkG OE. Following trypsin 
activation and washout, electrically silent channels were being delivered to the plasma membrane 
during the current run down time course. After 30 min, the cells were re-stimulated with trypsin. 
The increase from the base current is indicative of the number of channels delivered to the surface 
during the 30-min time period. B) Summarized Isc increase for the second trypsin pulse following 
the 30-min interval from n > 4. AnkG overexpression delivered 75% ± 16% more ENaC in 30 min 
than control cells (n = 4, p < 0.001). When in combination with the Liddle’s mutation, which 
prevents internalization and recycling/degradation, AnkG OE failed to increase the number of 
channels delivered to the surface in the second pulse, establishing that the increase seen in the 
second pulse is due to constitutively recycling channels being inserted into the membrane rather 
that from channels being delivered through the biosynthetic pathway. 
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Taken together these experiments indicate that AnkG increases the number of channels at 
the surface by facilitating the insertion of ENaC via the constitutive recycling pathway.  
2.2 INTRODUCTION - REGULATION OF ANKG-ENAC INTERACTION 
It has been demonstrated that CK2, a constitutively active and ubiquitously expressed 
serine/threonine kinase, regulates the interaction of AnkG and Nav1.2 in neurons by 
phosphorylating serine residues in Nav1.2’s AnkG binding motif [262]. Mutation of these serine 
residues resulted in diffuse localization of Nav1.2 rather than targeted localization to the AIS 
[262]. Previous studies have also established that CK2 phosphorylation increases ENaC activity, 
namely; CK2 phosphorylation of the C-termini of β- and γ-ENaC increases ENaC currents. CK2 
inhibition reduces ENaC activity and expression at the plasma membrane [54, 78]. 
Phosphorylation of these sites is believed to interfere with Nedd4-2 regulation, potentially through 
steric hindrance of an as yet unidentified protein.  
The C-terminus of β-ENaC contains a motif which aligns with 5 out of 7 of the conserved 
amino acids in the ankyrin-binding motif found in voltage-gated sodium and potassium channels 
(Fig. 2.19) [238]. Furthermore, this motif contains a regulatory CK2 site as well as an additional 
site phosphorylated by the kinase Grk2. The CK2 site in ENaC is homologous to a CK2 site 
associated with Nav1.2 and AnkG binding [79, 80]. The conservation of this CK2 site within 
ENaC’s putative ankyrin binding motif may point to a potential region of interaction between 
ENaC and AnkG. 
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Figure 2-19. Alignment of AnkG binding motif and βENaC C-terminus. Conserved residues 
are denoted with asterisks. The serine residue, β-S631 (mouse ENaC), is the site of CK2 
phosphorylation. 
 
2.2.1 Mutations to the CK2 and Grk2 phosphorylation sites of βENaC have minimal 
impact on base ENaC current and ENaC-AnkG phenotype  
To test whether to the CK2 and Grk2 sites in βENaC could impact the association between AnkG 
and ENaC, we mutated the S631 site to alanine or glutamate to create a site that could not be 
phosphorylated (phosph-dead, alanine) or a site mimicking a constitutively phosporylated site 
(phospho-mimetic, glutamate). We also created a S633E phospho-mimetic to act as a 
constitutively active Grk2 phosphorylated site. We then expressed these constructs in FRT cells 
with or without AnkG. Neither S631E nor S633E alone significantly altered the base ENaC 
current, suggesting these mutations were insufficient to improve endogenous interactions of ENaC 
with AnkG . Expressing S631E and S633E with AnkG significanly increased ENaC Isc relative to 
control, and there was no significant difference between WT+AnkG and S631E+AnkG or 
S633E+AnkG (Fig. 2.20B).  
We also tested the CK2 phospho-dead mutant construct (S631A) with or without AnkG 
and found no significant difference between control and S631A or AnkG and S631A+AnkG (Fig. 
2.19C). Lastly, βENaC has a glutamate residue (S630) that is conserved to a glutamate residue in 
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the AnkG binding motif of Nav1.5 (E1053). The charge reversal mutation, E1053K, causes 
Brugada syndrome in humans by disrupting the AnkG-Nav1.5 association [160]. We created the 
equivalent mutation (E630K) and tested its abiltiy to alter ENaC activity. We found no significant 
difference between control versus E630K nor AnkG versus E630K+AnkG (Fig. 2.20C). 
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Figure 2-20. Effect of phospho-dead and phospho-mimetic mutations of βENaC C-terminus. 
A) Diagram of the primary amino acid sequence of the βENaC c-terminus. The CK2 
phosphorylation site is β-S631, the Grk2 phosphorylation site is β-S633, and the charge reversal 
(-/+) site is β-E630 (mouse). B) Summarized Isc data of FRT cells expressing WT, phospho-
mimetic (βS631E), and phospo-mimetic (S633E) ENaC, with or without AnkG. In all conditions, 
addition of AnkG significantly increased currents (n≥24, p<0.001). Neither S631E nor S633E were 
significantly different from WT ENaC. There was also no significant difference between WT+ 
AnkG and S631E + AnkG or S633E + AnkG. C) Summary Isc data of FRT cells expression 
phospho-dead S631A and charge reversal E630K with or without AnkG. Addition of the mutations 
did not abrogate the effect of AnkG as addition of AnkG to all conditions resulted in significant 
increase in ENaC current (n≥10, p<0.05). The mutations alone did not impact overall ENaC 
current. The mutations also did not impact the magnitude of current increase with AnkG OE.  
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2.2.2 Pharmacological inhibiton of CK2 reduces ENaC current 
We also tested whether pharmacological inhibition of CK2 phosphorylation using 4,5,6,7-
tetrabromo-2-azabenzimidazole (TBB) altered ENaC currents. Overnight incubation of mCCD 
cells with 2µM TBB completely eliminated all detectable ENaC current (data not shown). This 
effect has also been seen in human bronchial epithelial cells (personal correspondance, Carol 
Bertrand). Acute treatment of control or AnkG KD mCCD cells resulted in an immediate reduction 
in current to final plateau within 10 minutes (Fig. 2.21A). While the final plateau current was 
significantly less in AnkG KD cells with 25µM TBB (Fig. 2.21B), there was no significant 
difference in the percent reduction between control and AnkG KD cells after normalization to the 
initial current (Fig. 2.21C). 
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Figure 2-21. Acute inhibition of CK2 phosphorylation in mCCD cells. A) Representative Isc 
of control or AnkG KD mCCD cells treated with TBB. B) Summarized Isc of control cells and 
AnkG KD cells before and after TBB treatment. C) Summarized results of percentage decrease 
following TBB treatment after normalization to initial currents. Acute CK2 phosphorylation 
inhibition resulted in a 70-75% decrease from initial currents in both control and AnkG KD cells 
(n≥4). 
 
2.2.3 Truncation of the putative βENaC AnkG binding motif does not eliminate the AnkG 
over expression phenotype 
These results demonstrate that if there is an interaction between AnkG and the C-terminus of 
βENaC it cannot be disrupted by a single-site mutation. We then tested whether loss of the putative 
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AnkG binding motif would impact the AnkG phenotype by inserting a stop codon at β-Q624. This 
truncation mutation still contains the Nedd4-2 binding PY motif. The truncation (β-Q624X), did 
not significantly alter currents relative to WT. Likewise, AnkG OE still increased ENaC currents 
even in the absence of the putative AnkG binding motif (Fig. 2.22). 
 
 
Figure 2-22. Effect of βENaC C-terminal truncation on AnkG OE phenotype. A) Primary 
sequence of the βENaC C-terminus depicting the Nedd4-2 binding PY-motif and the putative 
AnkG binding motif. A stop codon was intoduced a β-Q624 to create a C-terminal truncation. B) 
There is no significant difference between contol and truncated ENaC, and AnkG OE continues to 
increase ENaC current even with the C-terminal truncation (n≥12). 
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Thus it appears as though CK2 and Grk2 phosphorylation of the putative AnkG binding 
motif are not essential for AnkG mediated Na+ transport increased through ENaC. Additionally, 
removal of the putative motif had no impact on the AnkG OE phenotype suggesting that this may 
not be a binding site for AnkG, and/or that there are additional, unknown regions of interaction 
between AnkG and ENaC, perhaps in a different subunit. Further studies are needed to begin to 
more fully understand the mechanism influencing the AnkG-ENaC association. 
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3.0  DISCUSSION  
Ankyrins are a family of intracellular proteins that link integral membrane proteins via ankyrin 
repeats to spectrin based cytoskeletal structures and may play a crucial role in trafficking proteins 
to specific domains within the plasma membrane [263]. Although it has been known for some time 
that AnkG is highly expressed in the kidney [150, 198, 202, 240], the roles of this protein in kidney 
physiology and ion homeostasis remain largely uncharacterized. Previous studies have suggested 
AnkR and AnkG may be essential for basolateral sorting of the NKA and ammonium (RhBG) 
transporters, respectively [202, 219]. Work by San-Cristobal, et al.., has shown that AnkG inhibits 
current through the potassium channel Kv1.1, which establishes a favorable driving force for Mg2+ 
entry into the distal tubules of mice [228].  
Our previous work shows that AnkG expression is regulated by aldosterone-sensitive 
miRNAs, and that AnkG protein levels are upregulated following aldosterone stimulation due to 
repression of aldosterone-regulated miRNAs [20]. In order for AnkG to be physiologically relevant 
in the aldosterone signaling cascade, increased AnkG protein expression should lead to an increase 
in Na+ transport. We demonstrate here that AnkG increases Na+ transport via ENaC by increasing 
its constitutive recycling, but the affiliated intracellular compartments and interaction domains 
have yet to be elucidated. 
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3.1 ANKG EXPRESSION IN THE KIDNEY AND MCCD CELLS 
Earlier studies reported that AnkG was a basolaterally associated protein [150, 202, 231], but 
advances in imaging and biochemical approaches have demonstrated that it is also apical [22, 240, 
241]. The apical association of AnkG in the CD is essential for the potential interaction of AnkG 
and ENaC.  
At least two isoforms of AnkG are expressed in the kidney in varying amounts throughout 
the nephron in mice. Transciptomic data from the Epithelial Systems Biology Laboratory suggests 
that isoform 1, the 190kDa-AnkG is more predominant than the 270kDa-AnkG (isoform 2), and 
the highest levels of expression seem to be in the TAL, DCT, and CD (Fig. 2.1) [257]. Using 
immunofluorescence, we were able to detect AnkG in the nephron, both apically and basolaterally. 
A recent study by Stankewich, et al., analyzed ankyrin expression and localization along the 
nephron using immunofluorescence and TEM, and they observed AnkG at both the apical and 
basolateral membranes. Additionally, TEM images of kidney tubules from this paper show AnkG 
closely associated with some, but not all vesicles near the apical surface, whereas AnkG on the 
lateral side appears more tightly associated with the plasma membrane itself [240].  
We also detected AnkG in our mCCD cells at both apical and basolateral surfaces as well 
as in some intracellular punctae. This is in-line with recent data that found the 190kDa-AnkG 
isoform was identified as an apically associated protein in an apical membrane proteomics screen 
of cultured mouse cortical collecting duct (mpkCCD-clone 11) cells [241].  
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3.2 ANKG EXPRESSION RESPONSES TO ALDOSTERONE STIMULATION 
We have previously shown that AnkG expression increases in response to aldosterone stimulation 
[20]. Figure 2.4 shows that increase in expression using AnkG immunofluorescence in mCCD 
cells. 
In order to determine whether this change also occurred in aldosterone-stimulated 
collecting duct cells in vivo, we used immunofluorescence to detect AnkG expression in mice on 
low or normal Na+ diets.  Unlike in our mCCD cells, we did not detect a significant change in 
AnkG expression with aldosterone stimulation. We also failed to detect any changes in AnkG 
expression in rats fed high Na+ diets. It is possible that the increased expression is too subtle to 
detect using kidney IF; in our mCCDs the IF expression only increased by 32% (Fig. 2.4). A better 
way to interrogate these changes in the future may be to assess mRNA and protein levels in 
enriched CCD cell isolates, as RT-qPCR technology is more robust, and enriched cell isolates may 
increase the detectable signal for protein lysates. 
3.3 ANKG INCREASES NA+ TRANSPORT 
We were able to recapitulate the modifications to Na+ transport caused by changes in AnkG 
expression in three distinct cell models, namely, mCCDs, FRTs, and Xenopus oocytes, suggesting 
the validity of this interaction and possibility that this phenomenon may be wide spread (Figs. 2-
7, 2-11, 6.1). Both AnkG and ENaC are present in a number of different epithelia, so while the 
aldosterone-sensitive changes are likely kidney specific, AnkG may still have an important role in 
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maintaining or regulating ENaC activity in other tissues such as lung and skin, which have ENaC 
expression and AnkG isoform patterns similar to kidney [198].  
3.4 NKA LOCALIZATION AND EPITHELIAL CELL DIMENSIONS 
An additional reported function of AnkG is its role in determining lateral cell height in lung and 
kidney epithelial cells. We could confirm these observations in the mCCD cells and demonstrated 
that AnkG knock-down decreased lateral height in mCCD cells similar to previously published 
findings [184, 214, 215]. However, this height reduction appears to be compensated by an increase 
in cell width as we did not observe significantly altered apical or basolateral surface membrane 
area (Fig. 2-8).  
By isolating Na+ transport at the apical or basolateral membrane we confirmed that AnkG 
could increase Na+ transport via ENaC with no impact on NKA localization or function. This is 
surprising given the high expression of AnkG at the basolateral surface [202, 229, 240] as well as 
the established ability of NKA to bind ankyrins [231, 237, 243]. However, from these studies it is 
not clear whether AnkG binding of NKA has physiological importance, and as discussed in the 
introduction, the initial muddled understanding of the different ankyrins makes earlier research 
difficult to interpret. It is possible, that AnkG serves a structural role along the basolateral 
membrane, such as its anchoring effect on E-cadherin [215, 229], while near the apical surface, its 
association with vesicles plays a role in recycling.  
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3.5 CHANNEL NUMBER VS. OPEN PROBABILITY 
Our results suggest that AnkG increases ENaC Na+ transport by increasing the number of channels 
at the surface rather than by altering the Po of said channels. We demonstrated this using apical 
surface biotinylation and a locked ENaC mutant with a Po near 1.0 (Fig. 2-11). These results still 
allow for some debate. There are more direct measurements of open probability, such as single 
channel patch clamping that would more soundly establish whether AnkG can change Po. There 
remains the possibility that AnkG can change both number and Po, but changes to Po in our 
experiments were overwhelmed by larger effects from the change in number. It is also possible 
that AnkG could preferentially alter recycling of a particular cleavage state of ENaC, which would 
be an indirect, but affiliated effect on Po. There is some debate over whether proteolytic cleavage 
of ENaC can impact surface residency time, recycling, and degradation rates [102], and we do not 
currently know which intracellular compartments are associated with the variable processing states 
of ENaC or the constitutive recycling compartments involved with AnkG-ENaC interactions. 
However, conclusions from our studies indicate that AnkG increases ENaC surface number. 
3.6 EFFECT OF ENAC EXPRESSION IN MCCDS AND FRTS WITH ANKG OVER 
EXPRESSION 
We noted the impact of AnkG OE on ENaC expression levels in mCCDs vs FRTs. In our system 
with endogenous ENaC, AnkG expression had no effect on total ENaC protein. Conversely, when 
heterologously expressed with AnkG, expression of all three ENaC subunits was dramatically 
increased in FRT cells. Even with this increased expression, when we normalized to ENaC 
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expression, we found that AnkG increased channel surface number. There are a number of possible 
explanations for this difference. One possibility is the difference in AnkG isoforms and expression 
levels in mCCDs and FRTs. Figure 3.1 demonstrates that the predominant forms of AnkG in FRTs 
are the 190-kDa and 220-kDa isoforms; whereas the mCCDs express a 119 or 120-kDa isoform in 
addition to the 190-kDa (appears to have a slightly lower molecular weight in mice). We have also 
intermittently detected a higher molecular weight isoform in mCCDs; however, it appears to have 
very low expression. The lower molecular weight band around 75 kDa is likely a non-specific 
band as its expression did not decrease following siRNA knockdown with an RNA sequence 
targeting all AnkG isoforms. Additionally, it appears as though AnkG expression levels are much 
higher in mCCD cells than FRT cells.  
 
 
Figure 3-1. AnkG expression in FRT and mCCD cells. Representative Western blots of AnkG 
isoforms in FRT and mCCD cells. 
 
Another possibility to explain this phenomenon may be the effect of AnkG to shift ENaC 
from a degradative pathway into a recycling pathway. These cells are over expressing ENaC, 
which is likely taxing on the cells’ biosynthetic and degradative pathways. ENaC subunits are 
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targeted by ER associated degradation for proteasomal degradation during translation. AnkG over 
expression may allow for channels to be more rapidly removed from the TGN and localized to 
recycling compartments, reducing ER stress. If AnkG is contributing to an ENaC recycling 
compartment pool, perhaps more channels compartmentalized in recycling endosomes,thus 
resulting in fewer degraded channels and greater total ENaC expression. That is, the steady-state 
expression level of the channels has been shifted from degradation-associated endosomes to 
recycling endosomes with AnkG over expression, which would result in increased channel 
expression. Additionally, the formation of a unique recycling endosome corresponding to over 
expression of ENaC in FRT cells has already been described [260], so perhaps increased AnkG 
expression in these cells is having a similar effect. 
3.7 ANKG AND ENAC INTERNALIZATION AND CAMP-REGULATED 
RECYCLING 
Given the essential role of Nedd4-2 ubiquitination-dependent endocytosis in regulating the number 
of ENaCs at the membrane and the role of AnkG in endocytosis, it was unexpected to find that 
altering AnkG expression did not have a significant effect on ENaC internalization or cAMP-
stimulated trafficking of ENaC. These results were confirmed in both mCCD and FRT cells. 
Internalization rates in mCCD cells were investigated using cycloheximide treatment to inhibit 
protein synthesis while the functional half-life of channels at the surface was determined by the 
decrease in current over time (Fig. 2-13). In FRT cells, we utilized CR α- and λ-constructs to 
perform an electrical pulse-chase, which allowed us to determine the internalization rates of a 
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distinct pool of apical channels without complications caused by off-target effects of 
cycloheximide (Fig. 2-14). In both cases, AnkG expression did not alter internalization rates. 
To look at cAMP stimulated recycling, we performed repeated stimulation and washouts 
and compared the percentage change and rates of insertion and removal of the cAMP-regulated 
channels and found no significant differences (Fig. 2-15).  
3.8 ANKG INCREASES ENAC EXOCYTOSIS 
We therefore investigated apical surface delivery as the possible mechanism for AnkG’s action on 
ENaC. To isolate this step in the life cycle of ENaC in mCCD cells, the contribution of channels 
at the surface and in the cAMP-stimulated recycling pool were eliminated by irreversibly blocking 
these surface channels with phenamil, then the appearance of new channels at the apical membrane 
was determined as the increase in current over time. We found that AnkG OE increased apical 
surface delivery while AnkG KD reduced surface delivery (Fig.2-16).  
We also investigated whether AnkG OE increased surface delivery in FRT cells. Returning 
to our CR constructs, we followed the internalization of the activated pool for 30 minutes, and then 
added trypsin a second time. The increase in current resulting from the second trypsin pulse 
represents the number of new, inactivated ENaC channels that were delivered to the plasma 
membrane during the 30 minute wash-out period. Again, we found that AnkG increased the 
number of channels trafficked to the surface, further solidifying the data from our insertion 
experiments in mCCDs (Fig 2-17). 
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3.9 CONSTITUTIVE RECYCLING OR BIOSYNTHETIC DELIVERY? 
These apical delivery experiments informed us that AnkG was increasing ENaC exocytosis into 
the membrane, but not the pathway from which the channels were delivered. To begin to clarify 
this, we repeated the CR ENaC electric pulse chase experiments with the β-ENaC Liddle’s 
mutation, β-P616L. This mutation impairs normal, constitutive internalization and recycling of 
ENaCs from the membrane, allowing us to distinguish whether the increase in current from the 
second trypsin pulse originates from channels being delivered from the biosynthetic pathway or 
channels delivered from intracellular recycling compartments. If the channels delivered originate 
predominantly from the biosynthetic pathway, then addition of the Liddle’s mutant should not 
dramatically impact the magnitude of the second trypsin pulse. If the channels impacted by AnkG 
expression are predominantly from recycling compartments; however, the expected result is that 
normal endocytosis and recycling will be impaired by the Liddle’s mutation, and the second trypsin 
pulse will be blunted or abrogated. In fact, the latter result is exactly what we see (Fig. 2-18). As 
expected, addition of the Liddle’s mutation increased base currents, but when subjected to a second 
trypsin pulse, there were minimal channels at the surface, and no significant difference between 
control and AnkG OE. Also worth questioning is whether the internal recycling pool has sufficient 
ENaC to account for the observed changes in Na+ transport. By using kinetic modeling of 
internalization, recycling, and degradation rates, a study by Butterworth, et al. 2005, determined 
that mpkCCD cells have a large subapical recycling pool of ENaC channels [84]. This pool of 
channels represents roughly 75-85% of the total ENaC expressed in these cells. This corroborates 
with our data by establishing the feasibility that this large intracellular pool could result in the large 
changes to Na+ transport observed with AnkG knockdown or over expression.  These experiments 
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established that AnkG is accelerating constitutive recycling rather than increasing delivery of 
channels from the biosynthetic pathway. 
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Figure 3-2. Proposed model of the role of AnkG to increase Na+ transport in the collecting 
duct following aldosterone stimulation. AnkG is represented by the anchor associating with 
constitutive recycling. Circulating aldosterone crosses the basolateral membrane where it interacts 
with the mineralocorticoid receptor. This results in the decreased expression of a number of miRs 
targeting AnkG.  AnkG’s expression is then increased within the next 12-24 hours. AnkG then 
increases Na+ transport by increasing the number of ENaC at the apical surface through increased 
recycling rates. 
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Collectively, the experiments from the first results section demonstrate the role of a novel 
aldosterone-induced ENaC regulator which may contribute to Na+ handling in the distal nephron. 
We propose that following aldosterone stimulation, expression of key miRs targeting AnkG is 
reduced. This results in increased AnkG expression, which augments Na+ transport through 
association with ENaC. The ENaC-AnkG association increases the number of apical channels 
through an increase in constitutive recycling from intracellular stores. Overall, this helps maintain 
extracellular fluid volumes through increased Na+ reabsorption in the collecting duct. Uncovering 
AnkG as essential for ENaC surface delivery contributes to our general knowledge of ENaC 
trafficking, which has broader implications for blood volume homeostasis.  
3.10 INTERACTION DOMAINS AND POST-TRANSLATIONAL MODIFICATIONS 
IMPACTING THE ANKG-ENAC ASSOCIATION 
The C-terminus of βENaC has an amino acid sequence that shares some homology with a 
conserved AnkG binding motif found in voltage-gated Na+ and K+ channels [264]. Furthermore, 
ENaC is phosphorylated in this sequence by the kinases CK2 and Grk2 [54, 80], and the AnkG 
binding motif has been shown to be phosphorylated by CK2 in Nav1.2. This CK2 phosphorylation 
is important for AnkG association with Nav1.2 [262, 265]. Acute inhibition of CK2 with TBB 
reduced ENaC current, but the percentage decrease following inhibition was not significantly 
altered by AnkG expression (Fig. 2-21). To determine whether a phosphorylation event might be 
mediating an ENaC-AnkG interaction, we created phospho-mimetic and phosphor-dead mutations 
at these serines and tested their effect on ENaC activity and the AnkG OE phenotype. If 
phosphorylation at these sites is increasing AnkG association, we might expect that the phospho-
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mimetic mutations would increase ENaC current relative to WT, and perhaps the AnkG OE 
phenotype would be enhanced compared to WT+AnkG. Neither the CK2 nor the Grk2 phospho-
mimetics increased ENaC current relative to WT, and while AnkG OE increased their activity, the 
change was not significantly different from WT with AnkG OE (Fig. 2-20B). We also tested 
whether a phospho-dead CK2 mutation could impact ENaC current and/or the AnkG OE 
phenotype, but similarly found no significant difference between WT and the mutation or 
WT+AnkG and the mutation+AnkG (Fig. 2-20C). Lastly, there exists a charge-reversal mutation 
in Nav1.5 (E1053K) that causes Brugada syndrome by disrupting the Nav1.5-AnkG interaction 
and results in impaired surface expression in cardiomyocytes [160]. We tested whether a charge-
reversal mutation at the equivalent glutamate residue (β-E630K) could disrupt the AnkG 
phenotype, but found no significant difference compared to controls (Fig. 2-20C). One possible 
explanation for the lack of effects seen here is provided by experiments with Nav1.8. Using surface 
plasmon resonance experiments, Montersino, et al. examined the interaction kinetics of the AnkG 
binding motifs of Nav1.2, Nav1.8, and Nav1.9, and found that for Nav1.8, while CK2 
phosphorylation improved binding kinetics, AnkG could still bind to Nav1.8 when the serines were 
mutated to alanines due to the highly charged-acidic nature of its motif [218]. Perhaps the single-
site missense mutations were insufficient to completely disrupt the ENaC-AnkG association, or 
perhaps AnkG and ENaC are not interacting via the C-terminus of βENaC. 
To more fully examine this possibility, we generated a truncation mutation that removed 
the putative AnkG binding motif while keeping the Nedd4-2 binding PY-motif intact and 
expressed with or without AnkG.  When coexpressed with AnkG, the truncation did not reduce 
ENaC current, that is, loss of the putative AnkG binding motif did not change the increase in ENaC 
current caused by AnkG OE. There are several possible explanations for this. The most likely 
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explanations for this is that either AnkG and ENaC are not interacting here, or there is an additional 
site of association with the N-terminus of βENaC or the intracellular tails of α- and or λENaC that 
is strong enough to override the elimination of this site. It is also possible that the increase in total 
ENaC protein when coexpressed with AnkG may be overwhelming any smaller changes.Lastly, 
there are a number of different regulatory sites in this region including the phosphorylation sites 
and the Nedd4-2 binding motif, which could complicate experiments by having too many 
variables.  For now, the structural components underlying the association between ENaC and 
AnkG remain elusive. 
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4.0  SUMMARY AND FUTURE DIRECTIONS 
The aim of this research was to develop a better understanding of the role AnkG plays in regulating 
Na+ transport following aldosterone stimulation. I determined that Na+ transport through ENaC, 
but not NKA, could be altered by changing AnkG expression. Then I systematically isolated 
distinct pathways of ENaC biosynthesis and degradation. Namely, I isolated ENaC internalization, 
ENaC membrane insertion, cAMP-regulated recycling, and constitutive recycling. To do this, I 
used a combination of drugs and mutations impacting the biophysical properties of ENaC in 
combination with varying AnkG expression levels. I also used immunofluorescence and 
biochemical approaches to assess expression and localization of AnkG, ENaC, and NKA. I 
determined that AnkG increases Na+ by increasing apical recycling of ENaC.  
Questions remain, however, about which recycling compartments are involved and how 
AnkG, traditionally thought of as a scaffolding protein, relates to them and what additional players 
may be involved. We also do not know whether AnkG and ENaC interact directly, or through a 
larger macromolecular signaling complex. Further studies investigating the role of the N- and C-
termini of the ENaC subunits may begin to elucidate where this interaction takes place. A previous 
study has shown that the amiloride-sensitive Na+ channel co-immuniprecipitates with kidney 
ankyrin [87]. Additional co-immunoprecipiation or GST-pull down experiments using 
intracellular truncations and mutations may help determine which subunit/s interact with AnkG 
and where. It would also be of interest to determine where ENaC interacts with AnkG. Most likely, 
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it is in the MBD via 1 or 2 of the ANK repeats, as this is the AnkG domain that has been shown to 
interact with different ion channels [160, 191, 217, 218]. Along these lines, it would be interesting 
to know whether AnkG preferentially binds to cleaved or uncleaved ENaC, or whether AnkG 
association delays degradation of fully cleaved channels by increasing the likelihood that they 
move into a recycling compartment rather than get targeted to a late endosome and degraded. 
To further elucidate where in the recycling pathway AnkG is influencing ENaC, we could 
determine endosome specific compartments. Centrifugation combined with immune-isolation to 
separate different cellular compartments could be used to establish which Rab-specific and/or 
phosphoinositide lipid specific endosomal compartments are associated with both ENaC and 
AnkG [129],. These results would reveal more about the particular constitutive recycling 
compartments governing AnkG-mediated ENaC recycling as well as further clarify our 
understanding of ENaC proteostasis. A recent study has determined that AnkB acts as a major 
integrator of protein trafficking. After recognizing phosphatidylinositol-3-phosphate-positive 
vesicles, AnkG and Rab GTPase Activating Protein 1-Like (RabGAP1L) bind via AnkB’s DD, 
which results in AnkB’s recruitment to Rab22A-positive vesicles, which decreases Rab22A’s 
association with the early endosome vesicle [225]. This study determined that AnkB plays a critical 
role in Rab-mediated integrin recycling, which also provides additional support for the role of 
AnkG to increase ENaC recycling, and hints at very dynamic and integral roles for ankyrin-
mediated protein trafficking, as well as the likelihood that ankyrins function in macromolecular 
trafficking complexes. This research is particularly exciting, because Rab22 over expression 
appears to increase ENaC activity [266], and perhaps AnkG is functioning as a nexus between 
Rab22-ENaC compartments and another recycling endosome. 
Beyond this, it should be noted that AnkG is widely expressed in the kidney, and capable 
of interacting with a diverse range of transporters and cell adhesion molecules. We do not currently 
 111 
know whether the increases recycling associated with increased AnkG expression is an ENaC 
specific effect or whether it applies more globally to a variety of channels and transporters in both 
the kidney and other epithelial tissues. AnkG is highly expressed in the TAL and DCT as well as 
the CD, so it is possible that it also modules Na+ transport through association with NKCC2, NCC 
and/or other Na+ channels and transporters. The effect of AnkG on ROMK is also of interest as 
ROMK activity is linked to ENaC activity and increased following aldosterone stimulation [267]. 
Furthermore, AnkG has been shown to interact with a number of K+ channels, including Kv1.1 in 
the distal convoluted tubule. Ankyrins can associate with a number of different ion and solute 
transporters, many of which could be functionally relevant to kidney physiology, so investigation 
of K+, Cl-, HCO3- and others may reveal novel ion transport regulation. 
In order to study whether AnkG is having a global or ENaC specific effect, a number of 
different experiments could be proposed. For ROMK, Isc currents of ROMK expressed in FRT 
cells with or without AnkG could give an indication whether AnkG has an impact on K+ transport. 
Apical and basolateral permeabilization experiments would also help verify the ROMK specific 
effect, and if AnkG is impacting K+ transport on the basolateral membrane as well. Surface 
biotinylation or immunofluorescence could be used to determine whether AnkG increases the 
number of ROMK channels at the plasma membrane. To determine functional changes to the TAL 
and DCT transporters, NKCC2 and NCC, radioactive isotopes could be used to see changes in 
vectoral Na+ transport, and surface biotinylation or immunofluorescence could be used to assess 
surface expression. Additionally, immunoblotting of phosphorylated NCC can be used to see if 
the number of active transporters is altered by AnkG expression. Answering these questions could 
lead to additional experiments involving transporter trafficking, particularly whether AnkG also 
increases recycling or acts through additional, undetermined pathways. 
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Very little is known about transcriptional and translational regulation of ankyrins. Given 
its role in aldosterone signaling and association with transporters, it is possible that AnkG may be 
responsive to other hormones and signaling cascades important for transport regulation in the 
kidney. Preliminary studies looking at AnkG expression responses to insulin, AVP, cortisol, 
endothelin, and other molecules involved in distal nephron signaling may uncover additional 
functional components of these pathways. Our lab is working to identify novel miRs affliated with 
a number of these hormones, and an in silico analysis could help determine whether these miRs 
can target AnkG. Following this information, assessing miR-mediated AnkG expression could be 
determined through luciferase reporter assays and inhibition of the miRs in mCCD cells. Total 
AnkG expression would also be determined using Western blot and immunofluorescence 
following hormonal stimulation, and knockdown or over expression of AnkG in combination with 
hormonal treatment could help establish the relevance of AnkG in these signaling pathways if 
altered AnkG expression impairs ion transport. These experiments would further expand and 
enhance our understanding of hormonal AnkG regulation, and its role in ion transport in the 
kidney, 
But most importantly, when considering the physiological role of AnkG in the kidney, 
moving from cell models to animal models will provide the most solid evidence for the importance 
of AnkG in the kidney.  A conditional Cre/Lox AnkG mouse has already been created.  These mice 
could be bred to promoter specific mice allowing targeted deletion of AnkG in nephron specific 
regions. The physiological impact of these knockouts on electrolyte balance could then be 
determined using metabolic cages to determine changes in Na+, K+, H20 excretion. Also of interest 
would be determining whether the AnkG knockout mice have differences in circulating hormone 
levels such as aldosterone.  The ability of these mice to handle Na+ could also be tested using low 
and high salt diet challenges. Lastly, immunohistochemistry and isolated CCD populations could 
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determine whether AnkG expression is impacting ENaC expression, and the functionality of this 
could be determined using electrophysiology. 
My research has advanced the field by establishing the hormonal regulation of AnkG in 
collecting duct cells, and its ability to alter Na+ transport by increasing apical ENaC expression. 
This, however, only leads to more questions.  Where in the recycling pathway is AnkG impacting 
ENaC?  Is AnkG solely responsive to aldosterone, or do other hormones affect its expression as 
well? Is the effect of AnkG an ENaC specific phenomenon, or does it affect a broader range of 
channels and transporters in the kidney and other epithelia? Furthermore, if it is a more global 
effect, does it also impact these transporters by increasing their recycling, or it is involved in 
additional pathways? These questions can be addressed using a number of different experimental 
procedures in cell models; however, the eventual goal should be to translate these results to an 
animal model. Overall, it is clear we have much more to explore and learn about the role of AnkG 
in the kidney. 
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5.0  METHODS 
5.1 ANTIBODIES AND REAGENTS 
Chemical reagents were from Sigma Aldrich (St. Louis, MO) or Fisher Science (Pittsburgh, PA) 
unless noted otherwise. Antibodies against Ankyrin G were from Neuromab 
(immunofluorescence, clone N106/36, cat#73-146, lot# 437-5VA-5, Davis, CA) and Santa Cruz 
(Western blot, cat# sc-28561, lot#E2512). Polyclonal antibodies directed against the n-terminus of 
αENaC were previously described and obtained from Genescript[129] or Stressmarq Biosciences 
(cat# SPC-403D, lot# 130911). Polyclonal antibodies against β- and γENaC were obtained from 
Stressmarq Biosciences (cat# SPC-404D, lot# 150101, lot# 2653 and SPC-405D lot# PA-14299, 
respectively). Monoclonal antibodies against GFP and Na+/K+-ATPase were purchased from Santa 
Cruz (cat# sc-9996, lot# D2009 and cat# sc-21712, lot# D2213, respectively). V5-monoclonal 
antibody was from Invitrogen (cat# R960-25, lot# 1718556). Polyclonal ZO-1 antibody was 
purchased from Millipore (cat# AB2272, lot# NG1941611). 
5.2 CELL CULTURE 
Mouse cortical collecting duct (mCCDc-11) cells (provided by Laurent Schild and Bernard 
Rossier, Universitè de Lausanne, Switzerland) were cultured in 75-cm flasks (passage 28-38) in 
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2% FBS supplemented media as previously described [20, 268]. Cells for transfection were seeded 
onto 6-well dishes and transiently transfected with Lipofectamine 2000 according to 
manufacturer’s instructions. For overexpression, cells were transfected with 2µg of pEGFP-C1 
vector as a control (Clontech, Mountain View, CA) or AnkyrinG-190-GFP (Addgene, Plasmid 
#31059, Cambridge, MA). Transfection efficiency for the cDNA, assessed by GFP fluorescent 
signal, was consistently between 30-40% of cells. For knockdown, cells were transfected with 
25nM of a commercially available control RNA scramble sequence or dicer specific silencing 
RNA (DsiRNA) targeting AnkG. sequence 5’-ACACGUUAGAUAAUGUGAACCUGGU-3’ 
(Integrated DNA Technologies, Coralville, IA). The DsiRNA construct transfection efficiency was 
routinely 60-70%, as assessed by Cy®3 Transfection Control DsiRNA and AnkG 
immunofluorescent staining (Integrated DNA Technologies, Coralville, IA). 24 hours post 
transfection, cells were seeded onto 0.33cm2 or 1cm2 costar Transwell filters and allowed to 
polarize for at least 2 days before performing experiments [260].  
Fisher Rat Thyroid (FRT cells) from ATCC were grown in 5% FBS media in 75-cm flasks 
as previously described [260]. For transfection, cells were seeded onto 6-well plates and 
transfected with Lipofectamine 2000 using 0.6µg α-, β-, or γ-ENaC (wild type or cleavage resistant 
α (R202A/R205A/R208A/R231A) and γ (R143A/RKRK186QQQ)) [112], Liddle’s β (P616L), 
charge-reversal β (E630K), phospho-dead βENaC (S631A), and phospho-mimetic βENaC 
(S631E, S633E) with 1µg pEGFP-C1 or AnkyrinG-190-GFP. Following a 24 hour transfection, 
cells were seeded onto 0.33cm2 Transwell filters and cultured for two days before performing 
electrophysiological experiments.  
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5.3 MICE 
2 month old mice (n=3) from the C57Bl/6 strain were used for metabolic experiments to look at 
RNA and protein changes in whole kidney and collecting duct (CCD) enriched cell isolates. In 
order to obtain kidneys being stimulated by aldosterone, mice were started for 7 days on a standard 
diet, then placed in metabolic cages to measure food and water consumption, feces and urine 
excretion, and to collect urine. The mice were then switched to a low Na+ diet (Sodium Deficient 
Diet; Harlan Laboratories Inc., Frederick, MD) for 7 days, then placed in metabolic cages for 24 
hours, after which point, kidneys were collected from the animals for downstream experiments 
including CCD cell isolation, RT-PCR, Western Blot, and immunofluorescence. To obtain 
unstimulated kidneys, mice were placed on a low Na+ diet for 7 days, placed into metabolic cages 
for 24 hours, switched to a standard diet for 7 days, returned to the metabolic cage for 24 hours 
before kidney collection. Mice are kept in a temperature-controlled environment, which is 
overseen by a veterinarian on staff at the Rangos Research Center of the Children’s Hospital of 
Pittsburgh of UPMC and is approved by the American Association for the Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). The animals are monitored daily by 
research staff according to operation policies determined by the veterinarian.  Animals are isolated 
and gown, mask, gloves and shoe covers are required to access animal rooms. Adequate food and 
water, and disease control and prevention are maintained by animal facility staff. Mice would be 
removed from the proposed studies and euthanized early if they demonstrated inactivity, an 
inability to obtain food or water or an inability to ambulate. The planned procedures should not 
cause any discomfort to the mice, as there are no surgical procedures planned, and all mice will be 
euthanized prior to organ isolation. Mice with be euthanized by carbon dioxide inhalation.  This 
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method is consistent with the Panel on Euthanasia of the American Veterinary Medical 
Associations’ recommendations, and results in minimal pain to the animals.  
IACUC Protocol Number: 14094468  Animal Welfare Assurance Number: A3187-01 
5.4 IMMUNOBLOTTING AND SURFACE LABELLING 
Cells were lysed in lysis buffer (0.4% sodium deoxycholate, 1% NP-40, 10mM Tris, 50mM 
EGTA, pH 7.5) on ice for 15 minutes before pelleting insoluble material at 12,000rpm for 10 
minutes. Protein concentrations for lysates were determined using Bio-Rad protein assay 
according to manufacturer’s instruction, and 50µg of sample was run as total lysate lanes. Total 
cell lysates were denatured with 2x SDS-sample buffer with 200 mM DTT at 70°C for 15 minutes, 
separated on 7.5% SDS-Page gels and transferred to polyvinylidene difluoride membranes 
(Millipore). Membranes were blocked with 5% skim milk power in TBST (10mM Tris, 150mM 
NaCl, 0.05% Tween 20, pH 7.5) and probed with appropriate primary antibodies overnight at 4oC. 
After washing 3 times for 10 minutes each with TBST, membranes were incubated with 
horseradish peroxidase conjugated secondary antibodies in TBST with 5% milk for 1 hour. 
Membranes were again washed 3 times for 10 minutes with TBST, then treated with 
chemiluminescent substrate to visualized proteins of interest.   
 118 
5.5 BIOTINYLATION 
Unless otherwise noted, all steps took place on ice or in 4°C. Polarized FRTs on 24mm transwell 
filters, transfected with V5-tagged ENaC subunits (α, β, or γ) and either GFP (control) or AnkG-
190-GFP were washed 3x with PBS containing 0.1mM CaCl2 and 1mM MgCl2 (PBS/Ca/Mg). 
Sulfo-NHS-SS-Biotin was diluted (1.25mg/ml) in borate buffer (85mM NaCl, 4mM KCl, 15mM 
Na2B4O7, pH 9.0), and apical membranes were incubated with 1ml of the biotin-borate solution 
for 30 minutes with gentle agitation in the dark. Excess biotin was then quenched with 10% FBS 
in PBS/Ca/Mg. Filters were then washed (apical and basolateral) with PBS/Ca/Mg. Cells were 
lysed with biotinylation lysis buffer with protease inhibitors (same as above), and insoluble 
material was pelleted for 10 minutes at 12,000 rpm. Protein concentrations were determined using 
the Bio-Rad protein assay according to manufacturer’s instructions and equal amounts of protein 
(1.5mg) were probed overnight with V5-antibody (Invitrogen) and sheep-anti-mouse IgG 
Dynabeads (Invitrogen) with rotation at 4°C. Next the beads were washed once with 1% Triton-X 
in PBS/Ca/Mg, once with 0.01% SDS in PBS/Ca/Mg, and once in PBS/Ca/Mg. V5-bound proteins 
were eluted from the beads by incubation with 2% SDS in biotinylation lysis buffer for 10 minutes 
at room temperature. ENaC enriched eluate was brought to a final volume of 1ml, and the 
biotinylated fraction ENaC protein was probed overnight at 4°C with Streptavidin-conjugated 
Dynabeads (Invitrogen). The streptavidin beads were then washed 3x with biotinylation lysis 
buffer, and incubated in with 2x SDS-sample buffer with 200 mM DTT for 15 minutes at room 
temperature. For immunoblotting, biotinylated samples, as well as 30ug of total cell lysates and 
6ul of V5-ENaC enriched immunoprecipitate were run according to the above protocol. 
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5.6 IMMUNOFLUORESCENCE AND MICROSCOPY 
5.6.1 mCCD cells 
Polarized cells on filters were washed 3x with ice-cold PBS/Ca/Mg, then fixed with 4% 
paraformaldehyde for 25 minutes. After an additional 3 washes with PBS, cells were permeabilized 
with 0.25% Triton X-100 and 0.25% NP-40 in PBS for 20 minutes. Following an additional 3 
washes with PBS, cells were incubated overnight with primary antibody (1:50 dilution) in blocking 
buffer (10% fat-free milk in PBS) at 4⁰C. The next day, cells were washed 3x with PBS then 
incubated with secondary antibodies (1:500), Alexa-conjugated phalloidin (1:500), and/or Alexa-
conjugated wheat-germ agglutinin (1:2,000) in blocking buffer for 1 hour at room temperature. 
Cells were washed 3x with PBS and nuclei stained with a Hoescht dye (1:14,000) in PBS for 5 
minutes. After a final wash with PBS, the filters were mounted on coverslips with Fluoromount G 
(Southern Biotech). 
5.6.2 Mouse Kidneys 
For kidney staining, freshly isolated kidneys were fixed with 2% paraformaldehyde 2 hours, then 
submerged in 30% sucrose for 24 hours. Following this, the kidneys were submerged in 2-
methylbutane for 30 seconds before being snap frozen in liquid nitrogen. Samples were stored at 
-80°C until ready for sectioning. Kidney sections were performed on a cryostat 1 microtome 
(Center for Biological Imaging, University of Pittsburgh School of Medicine) at a thickness of 
4µM. Next the sections were rehydrated with 2 PBS washes. Kidneys were then permeabilized 
with 0.5% SDS in PBS for 20 minutes, then incubated in a quench buffer containing 50mM NH4Cl, 
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100mM Glycine, and 0.1% Sudan Black B in PBS for an additional 20 minutes. Samples were 
washed 5x PBS. Kidneys were incubated overnight with primary antibody then washed 5x with a 
high salt (3% NaCl) PBS and the 3x with normal PBS before incubating with secondary antibody 
(1:1000) or Alexa-Fluor conjugated phalloidin for 1 hour at room temperature. Kidneys were 
washed 5x with PBS then incubated with Hoescht to stain the nuclei, and washed a final 5x with 
PBS before mounting. 
5.6.3 Rat Kidneys 
Paraffin embedded kidney from rats on low Na+ (0.4% NaCl) diets or high Na+ (8% NaCl) were 
generously provided by Alexander Staruschenko (Medical College of Wisconsin). Kidney 
sectioning, subsequent rehydration, and citrate buffer antigen retrieval was performed by the Starzl 
Transplantation Institute Research Histology Services at the University of Pittsburgh. Kidney 
sections were incubated 2x with washing buffer (PBS + 0.025% Triton-X) for 5 minutes. Next, the 
sections were submerged for 1 hour with blocking buffer (5% normal donkey serum and 1% BSA 
in PBS). Primary antibodies were diluted in PBS with 1% BSA (1:100), and probed overnight at 
4°C. The following day, slides were washed 3x for five minutes in washing buffer. Secondary 
antibodies were diluted in PBS with 1% BSA (1:500) and slides were incubated for 1 hour at room 
temperature in the dark. The slides were then washed 3x for 5 minutes in washing buffer, followed 
by a 5 minute incubation with Hoescht (1:10,000 in water). After a final 3 washes with PBS, kidney 
sections were mounted with Fluoromount G under glass coverslips. 
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5.6.4 Confocal Microscopy 
Images were capture on a confocal Nikon A1 Plus microscope using a Plan Apo λ 10x numerical 
aperture 1.23, Plan Apo VC 60x Oil DIC objective with 1.4 numerical aperture or Plan Apo λ 100x 
Oil numerical aperture 1.45, controlled by Nikon Elements AR software (Nikon, Tokyo, Japan) at 
the University of Pittsburgh Center for Biologic Imaging. Lateral cell heights and cell widths were 
determined using line analysis and computed by Nikon Elements AR software. AnkG 
immunofluorescence (IF) intensity in whole kidney was measured using square regions of interest 
(ROI) from a series of images from cortex and medulla (N=4, n>8). For total kidney AnkG 
expression, the mean IF signal was normalized to the nuclear fluorescence. For collecting duct 
specific AnkG IF intensity, freehand ROIs surrounding only CD tubules (as determined by AQP2 
positive staining), were drawn and sum fluorescence signal was normalized to the number of cells 
within the ROI (n>40). To determine summed AnkG fluorescence in 1µm thick z-stack images, 
freehand ROIs were drawn surrounding individual cells. Then ZO-1 staining was used to 
determine the apical vs basolateral frames, and AnkG fluorescence was summed for all frames for 
either region to determine approximate AnkG distribution in mCCD cells. 
5.7 ELECTROPHYSIOLOGY 
Cultured cells on 0.33 cm2 Transwell filter supports were mounted in modified Ussing chambers 
(P2300, Physiological Instruments, San Diego, CA) bathed in 4ml Ringer’s Solution (120mM 
NaCl, 25mM NaHCO3, 3.3mM Kh2PO4, 0.8mM K2HPO4, 1.2mM MgCl2, 1.2mM CaCl2, 10mM 
glucose, pH 7.4) in each hemi-chamber and bubbled with 5% C02 at 37°C, as previously described 
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[20, 84, 129, 260]. Short circuit currents (Isc) were obtained with an automatic voltage-clamp 
(VCC MC8, Physiological Instruments, San Diego, CA). Transepithelial resistance was measured 
by applying a 2mV bipolar pulse and calculated using Ohm’s law. In some experiments, Isc and 
total membrane capacitance were measured simultaneously with an automated voltage-clamp 
system (designed by W. Van Driesche KU Leuven, Belgium) as described previously [84, 269]. 
Briefly, the equipment comprised of two Digital Signal Processing (DSP) boards, one which 
recorded Isc, and one which recorded epithelial capacitance (CT). Recordings were digitized using 
PowerLab (Ad Instruments, Colorado Springs, CO). For basolateral permeabilization experiments, 
the basolateral chamber contained at Low Na+ Ringer’s solution in which 120mM NaCl was 
replaced with N-methyl-D-glucamine chloride (NMDG-Cl). To stimulate cAMP, 5µM forskolin 
was added basolaterally. To determine ENaC-sensitive Isc, 10µM amiloride, or 25µM phenamil 
was added apically, while Na+/K+-ATPase’s contribution was determined by addition of 30µM 
ouabain, basolaterally. Electrically silent, uncleaved ENaC channels were activated by apical 
addition of 1µM trypsin. When washing out phenamil or trypsin in the electrical pulse-chase 
assays, chambers were washed 6 times with a total of 25-30mL Ringer’s solution.  
5.8 STATISTICS AND CURVE FITTING 
All data were analyzed using GraphPad Prism. Data from multiple replicates were normalized to 
control values for each experiment. Unpaired student t-tests were performed to evaluate statistical 
significance, with p-values <0.05 considered significant. Curves were fit using non-linear 
regression analysis of data points averaged from multiple experiments. The rate of removal of 
channels from the surface (FRT cleavage resistant ENaC and mCCD forskolin wash out 
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experiments) was modeled as y=(y0-plateau)*e-Kx + plateau where y0 is the y value at x=0, the 
plateau is the steady state Isc, K is the rate constant expressed as min-1, and x is time in minutes. 
Channel membrane insertion curves (mCCD forskolin stimulation and phenamil recovery) are one-
phase association curves, given as y=y0+(plateau-y0)*(1-e-Kx) where y0 is the initial y value, 
plateau is the steady state Isc, K is the rate constant expressed as min-1, and x is time in minutes. 
Data are presented as mean +/- standard error of the mean (SEM), and *, **, and ** indicate 
significant difference from control where p<0.05, p<0.01, or p<0.001, respectively). 
 
  
124 
APPENDIX A 
Figure 6-1. AnkG expression increases ENaC current in oocytes. Oocytes isolated from 
Xenopus laevis were injected with ENaC and increasing amounts of AnkG RNA. ENaC currents 
increased with increasing AnkG expression. These results demonstrate that the effect of AnkG on 
ENaC activity can be recapitulated in an alternative expression system. 
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